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           In this dissertation, mesoporous silica thin films with tunable features at the 
nanoscale were fabricated using the triblock copolymer template pathway, with the aim 
of specifically harvesting the low molecular weight peptides and proteins from human 
serum, which has been regarded as a potential source of diagnostic biomarkers for the 
early detection of disease. The superior properties of mesoporous silica have been 
demonstrated in applications which include chemical sensing, filtration, catalysis, drug-
delivery and selective biomolecular uptake. These properties depend on the architectural, 
physical and chemical properties of the materials, which in turn are determined by the 
processing parameters in evaporation-induced self-assembly (EISA). Using the different 
polymer templates and polymer concentration in the precursor solution, various pore size 
 viii
distributions, pore structures and surface hydrophilicities were obtained and applied for 
nanotexture-selective recovery of low mass proteins. With the assistance of mass 
spectrometry and statistic analysis, we demonstrated the correlation between the 
nanophase characteristics of the mesoporous silica thin film and the specificity and 
efficacy of low mass proteome harvesting. In addition, to overcome the limitations of the 
pre-functionalization method in polymer selection, plasma ashing was used for the first 
time for the treatment of the mesoporous silica surface prior to chemical modification. 
Opposite surface charges due to the different functional groups used, resulted in a 
distinctive selectivity of the low molecular weight proteins from the serum sample. The 
mesoporous silica chips operate with extraordinary rapidity, high reproducibility, no 
sample pre-processing, and substantial independence from sample acquisition and storage 
temperature.In conclusion our study demonstrates that the ability to tune the physico-
chemical properties of mesoporous silica surfaces has the potential to promote the use of 
this material as a tool for the selective separation and concentration of the low molecular 
weight proteome from complex biological fluids.  
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NANOTECHNOLOGY AND EARLY DIAGNOSTICS 
1.1 Overview 
Many diseases, including cancer, originate from mutations and alterations to 
normal cellular regulatory and metabolic pathways at a molecular level. [1, 2] Accurate 
and sensitive diagnosis (e.g. early diagnostics) has been constrained by the lack of 
biosensors and molecular probes capable of rapidly recognizing the distinct molecular 
features of these diseases.  Nanomaterials are defined as materials comprised of basic 
components which have at least one dimension in the nanoscale (less than 100 nm.)  
They have had an impact on the field of biomedical research even before the term 
nanomedicine was coined. [3] The ability of nanomaterials and nanopatterned devices to 
directly interact with biologically significant molecules and to convert those interactions 
into transduced or significantly amplified electrical or electromagnetic signals has 
ushered in a new generation of early stage diagnostic techniques.  
The interface between nanosystems and biosystems is emerging as one of the 
broadest and most dynamic areas of science and technology, bringing together biology, 
chemistry, physics and many areas of engineering, biotechnology and medicine. The 
combination of these diverse areas of research promises to yield revolutionary advances 
in healthcare, medicine and the life sciences through, for example, the creation of  
powerful tools that enable direct, sensitive and rapid analysis of biological and chemical 
species for the diagnosis and treatment of diseases. The greater the detail with which the 
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molecular components of a specific disease can be determined, the more specifically the 
therapeutic regimen can be tailored to the individual. [4] These nanoscale structures 
represent powerful diagnostic tools as they can be surface functionalized with a range of 
specific targeting agents or amplification modalities and then systemically circulated to 
locate and monitor specific biological components. The development of microfluidics 
and “lab on a chip” systems with specifically designed nanoscale features allows for the 
combination of multiple complex diagnostic procedures into one simple device for point-
of-care diagnosis. Many products have emerged for laboratory clinical and diagnostic 
uses including separation technologies for blood into its components, the fractionation of 
complex biofluidic mixtures into, e.g., its protein and nucleic acid digest sub-populations, 
DNA amplification strategies via PCR-on-chip, precise fluidic dispensation technologies 
for automated high-throughput analyses, multiplexed analyte sensors for point-of-care 
diagnostics, and many more.   Despite the enormous potential of nanotechnology as it 
relates to diagnosis, many important concerns must still be addressed including the 
toxicological effects of the in vivo use of the relevant nanomaterials, the identification of 
appropriate target molecules and biomarkers to be screened for, the proper protocols for 
sample preparation, and the complete interpretation of diagnostic results obtained from 
both animal models and human trials.  The ability to address these concerns will 
ultimately determine how extensively nanotechnology driven diagnostic techniques can 
percolate into the clinic.  
Presently, conventional radiological diagnostic techniques focus on detecting the 
physical manifestations of disease. Given the high correlation between survival rate and 
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early detection [5], it is highly advantageous to identify abnormal cellular function before 
significant physiological modifications become apparent.  Mammography is the process 
of using low energy x-rays to examine the human breast for characteristics masses or 
microcalcifications. It is a widely used technique because its relatively low cost and 
operational simplicity allow for population-wide screening.  Regular mammographic 
screening can detect between 80 and 90% of breast cancers in asymptotic individuals, 
resulting in reduced breast cancer mortality. [4] However, for women with dense breasts 
the sensitivity of mammography is low (45.8%-55%). [6] Furthermore, successful 
screening and diagnosis rely too heavily on the skill and experience of the radiological 
practitioner.  Finally, this imaging-based technology requires a critical mass of localized 
accumulated tumor cells for effective neoplasm identification and is therefore not capable 
of detecting tumors with masses or densities below this critical dimension.  The 
diagnosis of breast cancer can be also accomplished by directly analyzing tumor cells 
through techniques such as the cytomorphology of exfoliated cells. [7] However, due to 
the subjective nature of tumor cell identification and the labor-intensiveness of the 
process, direct visualization of tumor cells does not lend itself to regular population-wide 
screening of asymptomatic women.  Several studies have recognized that diagnostic 
biomarkers isolated from blood, such as circulating proteins and nucleic acids, may offer 
the greatest potential for the  earliest and most reliable screening of diseases. [8-10] 
Without the assistant of nanomaterials and nanotechnologies, the identification and 
screening of potential biomarkers is unlikely to overcome the inherent requirements of 
high throughput and sensitivity. For example, the breakthrough in utilizing inorganic 
 4
nanoparticles for contrast enhancement in imaging biomarkers provides a robust 
framework for biomedical application. [11-15] The marriage of biology and micro-
/nanofabrication has revolutionized biosensing by allowing for the integration of 
biological recognition elements into devices that will significantly impact the commercial 
availability of detection and diagnostic technologies at the genome, proteome and 
metabolome levels.  This should dramatically decrease the time between disease onset 
and the initiation of tailored medical intervention and thus greatly increase the likelihood 
of a positive clinical outcome.  
In this chapter we will discuss disease diagnosis by means of molecular 
recognition, genomic analysis, and proteomic analysis. Several of the most promising and 
advanced nanotechnologies relevant to achieving the goal of the earliest possible 
detection of abnormal cellular function will be summarized. First we will give an 
introduction about the study in this dissertation: using mesoporous silica chips for rapid 
proteomic and genomic screening of blood and plasma, as compared to conventional 
proteomic technologies. Next we will briefly cover some other nanopatterned devices and 
nanomaterials used in diagnostics, including nanowire biosensors, micro- and 
nanocantilevers, single electron transistors, the DNA-based nanobarcodes, quantum dots, 
and gold nanoparticles. We will also discuss magnetic nanoparticles, predominantly as 
contrast agents for magnetic resonance imaging.  
 
1.2 Molecular Recognition in Diagnostics 
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1.2.1 Origin of Biomarkers  
Understanding how a normal cell transforms into a diseased cell is crucial for 
developing diagnostic technologies.  A large component in the regulation of normal 
cellular function occurs through the interaction of extracellular components with 
receptors on the cell membrane surface which trigger specific signaling pathways within 
the cell. Both the cell surface receptors and the subsequently triggered signaling 
pathways are composed of specific evolutionarily designed molecules. These cellular 
structures and signaling pathways also allow the cell to respond to changes in its external 
physiological environment.  The molecular processes in one pathway then trigger other 
pathways in precise sequence. These propagated signals may cause a change in cell 
behavior or in gene expression, resulting in a response at the cellular or molecular level. 
Understanding how these specific pathways malfunction can provide scientists, 
pharmacists, and clinicians with possible molecular targets that can be used to generate 
new diagnostic strategies. In the case of tumor progression, Hanahan and Weinberg have 
defined six important subcellular regulatory systems whose malfunctioning is required 
for most cancers (See Figure 1).  These malfunctions include the acquisition of self-
sufficiency in growth signals, insensitivity to anti-growth signals, limitless replication, 
evading apoptosis, sustained angiogenesis, and tissue invasion and metastasis. [16] 
Cancer represents a class of diseases containing over 100 subtypes whose distinguishing 
characteristics are related to the tissue of origin and the type and nature of the 
malfunction of specific molecular pathways. Molecular diagnostics is based on the 
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detection of abnormal nucleic acids sequences, proteins, and other biomolecules derived 
from biological fluids (serum, urine, saliva, cerebrospinal fluid),  which comprise the 
machinery, or in some cases the by-products, of these regulatory signaling pathways and 
can therefore be indicative of diseased states. [17] 
 
Figure 1.1: The six hallmarkers of cancer. It was suggested that most if not all cancers 
have acquired the same set of functional capabilities during their 
development, albeit through various mechanistic strategies. (Reprinted, with 
permission from Ref. [16] Copyright 2000 Cell.) 
 
1.2.2 Genomics and Proteomics in Disease Diagnosis 
As we introduced above, cancer is a diverse disease. Current diagnostics 
modalities have obvious limitations to provide an accurate prediction based on the 
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varying situation between individual patients, even when they are at the same clinical 
stage. Therefore, the next level of molecular diagnostics is needed: diagnostics that are 
focused on the personalization of medicine.  
A gene is a segment of DNA that encodes for a specific protein, including the 
mechanisms for gene expression and protein synthesis. Therefore, human disease is 
thought to be largely genetic in etiology. Genomics is the study of the structure and 
function of genetic material in chromosomes and regulates the gene expression patterns 
to correlate with the classification and prediction of diseases. The spectacular success in 
sequencing the complete human genomes has dramatically advanced the possibility of 
realizing personalized medicine. With the development of gene chips, microarrays and 
bioinformatics, genomics has moved to a functional phase where gene expression can be 
determined by detecting gene-specific mRNA sequences. Fully understanding the 
molecular processes leading from health to disease, however, is considerably more 
involved than identifying active gene sequences. Increasingly, Attention has being 
focused on proteins and enzymes and their interactions which determine cellular 
architecture and function. [18-20] 
For many diseases, such as cancer, protein function is altered in the context of key 
signaling pathways that regulate critical cellular functions including proliferation, 
apoptosis, differentiation, survival, immunity, metabolism, invasion and metastasis. 
Understanding which combinations of protein regulatory networks are dysfunctional, and 
which specific nodes in the cell circuitry are dysfunctional may be critical to the 
development of effective combinations of pharmacologic inhibitors. [21] Proteomics, in 
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contrast to genomics, refers to the systematic study of the total protein complement 
expressed by the genome of particular cells or tissues, both healthy and diseased. [22, 23]  
Proteomic studies to determine the structure and function of each protein and the 
complexities of protein-protein interactions will be important for developing accurate, 
effective, and timely diagnostic and therapeutic modalities. Currently, a number of 
techniques, including western blots [24], immunohistochemical analysis [25], enzyme-
linked immunosorbent assays (ELISA) [26] and mass spectrometry [27], allow us to test 
for specific proteins  and thus diagnose a particular disease. There is no doubt, however, 
that completely defining the human proteome is going to involve a very different set of 
challenges than the sequencing the human genome. As an example, it is essential to know 
the concentration of a particular protein and not just its presence in order to determine its 
functional activity.  Therefore, the accurate quantification of low abundance proteins is 
one of the biggest challenges in the study of proteomics. Proteomic biomarkers are 
important tools for cancer detection and monitoring. They serve as hallmarks for the 
physiological status of a cell at a given time and change during the disease process. 
Fortunately with the aid of advanced protein-based nanotechnology methods capable of 
detecting zeptogram quantities, this problem can be overcome and will be of great use for 
specific and sensitive diagnosis. [28-30] By linking genomic or proteomic biomarkers 
and clinic-pathological parameters, scientists and physicians will be able to identify 




1.2.3 Low Molecular Weight Proteome in Human Serum 
Discovering the novel specific biomarkers for early disease detection is the key to 
develop medicine to combat complex diseases such as cancer. The identification of 
circulating biomarkers holds great potential for non invasive approaches in early 
diagnosis and prognosis, as well as for the monitoring of therapeutic efficiency. [31, 32] 
Scientists presume upon the characterization of the thousands of individual serum 
proteins/peptides to enable the discovery of an increasing number of reliable disease 
biomarkers. Because of its high protein content (i.e. 60-80 mg/ml), human serum is 
expected to provide valuable information for proteomic investigation. [33, 34] Mounting 
evidence confirms that the circulating low molecular weight proteome (LMWP), 
composed of small proteins shed from tissues and cells or peptide fragments derived from 
the proteolytic degradation of larger proteins has been associated with the pathological 
condition in patients and likely reflects the state of disease. [35-37] 
 
 
Figure 1.2: the low-molecular-weight region of the blood proteome is a treasure trove of 
diagnostic information ready to be harvested by nanotechnology. (Reprinted, 
with permission, from Ref. [35]. Copyright 2003 Nature.) 
 
 10
Despite these potential clinical applications, the use of Mass Spectrometry (MS) 
to profile the LMWP from biological fluids has proven to be very challenging due to the 
large range of protein and peptide concentrations in serum, spanning more than 10 orders 
of magnitude. In addition, the protein content of serum is dominated by a handful of 
proteins such as albumin, haptoglobulin, immunoglobulins, and lipoproteins. As 
exhibited in Figure 1.3, 10 proteins make up 90% of the protein content of serum. 12 
other proteins constitute the majority of the remaining 10%. In fact, only 1% of the entire 
protein content of human serum is made up of LMW proteins that are considered to be of 










Figure 1.3: Pie chart representing the relative contribution of proteins within plasma. 
Twenty-two proteins constitute 99% of the protein content of plasma. 
(Reprinted, with permission, from Ref. [38] Copyright 2003 The American 
Society for Biochemistry and Molecular Biology, Inc.) 
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Without sample pre-treatment, some of the more bundant proteins obscure the 
detection of low-abundance species in serum/plasma. This ultimately limits the resolution 
of most protein screening methodologies in the range of protein sizes of diagnostic 
interest. Furthermore, many common enzymes (i.e. thrombin, plasmin and complement 
proteins) also circulate in the blood that may initialize endoprotolytic cleavage and cause 
the LMWP signature to be altered during sample processing. For this reason sample 
collection, storage, and processing must be carefully standardized and documented and 
occur within a specifically controlled duration. 
 
1.2.4 Conventional Proteomics-based Approaches 
The introduction of proteomic tools, especially development in mass spectrometry 
(MS) [39, 40] has allowed for the investigation of complex proteomes and the 
identification of proteins in cells, tissues and body fluids, increasing the interest of 
proteomic biomarker research. [41] Now there are several different proteomic based 
approaches that can be used to attempt to discover novel biomarkers. Three of the most 
popular techniques are discussed herein. Two-dimentional polyacrylamide gel 
electrophoresis (2D-PAGE) is widely used to separate the mixtures of proteins in two 
dimensions by two properties, such as isoelectric point, protein complex mass in the 
native state, and protein mass. In their application in proteomic study, they primarily 
analyze bio-markers by identifying individual proteins, and showing the separation 
between one or more protein "spots" on a scanned image of a 2D electrophoresis gel. 
Furthermore, spots matched between gels of similar samples are able to show proteomic 
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differences between early and advanced stages of an illness. However, 2D-PAGE 
requires a large amount of protein as starting material, and the technique cannot be 
reliably used to detect and identify low-abundance proteins because of their poor fluidity 
in gel. These disadvantages, in addition to weak spots/noise and unmatched/undetected 
spots leading to missing values, represent a significant obstacle to search for biomarkers 
in early-stage cancers. Surface enhanced laser desorption and ionization time-of-flight 
(SELDI-TOF) MS is a method to use on-chip protein fractionation, which is dependent 
on the type of chromatographic matrix used, such as weak cation, strong anion or 
immobilized metal affinity. As a result of the interaction occurring on the chip surface, a 
subset of the proteins in the sample binds to the substrate. This interaction is specific as 
the chromatographic binding is based on the inherent amino-acid sequence of any given 
protein, as well as on the pH, detergent and salt concentration in the binding reaction 
buffer. Although SELDI-TOF technology has a clear advantage in that just a minuscule 
amount of input material is required, a caveat to its efficacy is that substantial upfront 
fractionation of protein mixtures and down-stream purification methods are required to 
obtain absolute protein identification, ultimately resulting in a lack of reproducibility. A 
number of studies have used SELDI technology to identify specific disease-related 
biomarkers for several types of cancer. Protein array is another very active research 
program that studies the abundance or the extent of modification of particular proteins 
through their interaction with specific affinity reagents such as antibodies or aptamers. 
But it is limited by antibody sensitivity and specificity. These proteomic-based 
approaches for serum fractionation are labor-intensive, low throughput and offer limited 
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suitability for clinical applications, especially for those based on the identification of 
LMWP.  Therefore, a more effective strategy is needed to isolate LMWP from blood and 
allow the high throughput screening of clinical samples.  
 
1.3 Objective of the Dissertation 
LMWP extracted from serum has the potential to reflect ongoing pathological 
conditions. However, in order to profile the LMWP, there are significant technical 
challenges that must be overcome. Specifically, progress must be made regarding the 
development of fast, reliable, and highly sensitive and specific sample analysis methods. 
The main objective of this research is to develop a nanotechnology-based strategy using 
nanoporous silica chips for the efficient removal of the high molecular weight proteins 
and for the specific isolation and enrichment of LMW species present in complex 
biological mixtures.  
These nanoporous silica chips were synthesized using a process that began with 
the self-assembly of a mixture of a triblock copolymer (poly(ethylene oxide) (PEO)-
poly(propylene oxide) (PPO)- poly(ethylene oxide) (PEO)) and hydrolyzed silicate 
precursors. [42, 43] The preferential evaporation of the solvent after dip or spin coating 
drives the self assembly of this mixture into a uniform thin-film nanophase by increasing 
the concentration of polymer in the solution until it exceeds the critical micelle 
concentration. Nanoporous silica thin films with narrow nanoscale pore size distributions 
and high surface area to pore volume ratios were formed after removing the organic 
template through calcination. In Nanoporous Silica Chip Technology, tunable pore sizes, 
 14
structure and surface chemistries act as integrated “processors” for the selective depletion 
of the high molecular weight protein content in serum samples and for the enrichment of 
LMW peptides and proteins. [44-46] The detailed synthesis mechanism of mesoporous 
silica thin film will be discussed in the next chapter. 
Serum fractionation using the mesoporous silica thin films was carried out by a 
rapid 4-step on-chip strategy shown in Figure 1.4. The sample is first spotted on the chip 
surface (step 1) and incubated to allow the low molecular weight (LMW) proteins to be 
trapped in the pores (step 2). Next the chip surface is washed to remove the larger protein 
species which remained outside the pores. The enriched small molecules are then eluted 
from the nanopores (step 3) and subjected to further mass spectrometry (MS) analysis 
(step 4). To validate this approach in the context of complex biological samples, the MS 
profiles of human serum before and after fractionation using the mesoporous chips were 
compared, shown in Figure 1.5. After washing using deionized water the larger proteins 
were shown to have been thoroughly removed as demonstrated by a dramatic reduction in 
signal intensity compared to that of the LMW proteins and peptides. The proteomic 
profiles depicted in Figure 1.5 (e, f) clearly demonstrate the efficiency of this 
fractionation strategy in eliminating most of the abundant high molecular weight (HMW) 
proteins and enriching the otherwise undetectable LMW species present in the serum.  
This added sensitivity in the LMW portion of the spectrum is crucial for biomarker 











Figure 1.4: Schematic of the harvesting protocol consisting of (1) deposition of plasma 
directly onto the chip surface; (2) washing of unbound substances; (3) 
extraction of bound molecules; and (4) MS analysis. (Reprinted, with 
permission, from Ref.[46]. Copyright 2006. American Chemical Society) 
 
By tuning the chemo-physical properties of nanoporous silica surfaces we 
demonstrated for the first time the correlation between pore size and molecular cut-off. 
Reproducibility, sensitivity and protein profiles were assessed in relation to the physical 
(pore size, pore connectivity and structure) and chemical (surface charge, hydrophobicity, 
hydrophilicity) properties of nanoporous silica. Finally, we applied the Nanoporous Silica 
Chip Technology to the analysis of human serum and developed different proteomic 
chips to specifically target regions of the human LMW circulating peptidome. Harvested 
peptides were subjected to MALDI analysis and profiles consisting of more than 300 
peaks in the range 800-20 000 m/z were generated. Our results demonstrate that 
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nanoporous silicon chips are valuable tools for the detection of low abundance LMW 
peptides in complex solutions such as serum. Furthermore, the evaluation of the 
differential recovery of peptides and proteins from human serum is performed from 
statistical analysis of spectrographic profiles obtained using mass spectrometry, a well 
established technique. We envision that screenings based on our nanoporous silica chip 
technology may serve as a complement to histopathology, molecular imaging, and other 
state of the art diagnostic techniques. This approach may help in the selection of 
individualized therapeutic combinations that target the entire disease-specific protein 
network, in the real-time assessment of therapeutic efficacy and toxicity, and in the 
rational modulation of therapy based on changes in the protein network associated with 




Figure 1.5: MALDI-TOF profiles of human plasma using as matrixes CHCA (left panels) 
and SA (right panels). a, b:  control experiment without chip incubation 
(direct MS analysis with no pretreatment); a plasma aliquot was diluted 100-
fold with matrix for MS analysis analysis. c, d:  control experiment using a 
solid silica surface (nonporous). e, f:  analysis of human plasma proteins after 
exposure to a nanoporous silica chip. All experiments used 5 μL of human 
plasma spiked with calcitonin at a concentration of 1 μg/mL. For obtaining 
spectra c and e, chip surfaces were extracted directly with matrix solution; for 
spectra d and f, the extract was instead mixed with matrix in a subsequent step 
(matrix/extract ratio 3:1). The calcitonin peak, only visible in panel “e”, is 
marked with a star. (Reprinted, with permission, from Ref.[46]. Copyright 
2006. American Chemical Society) 
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1.4 Literature Review - Other Nanodevices and Nanomaterials in 
Diagnostics 
Realizing the full potential of nanotechnology as it pertains to genomic and 
proteomic diagnosis requires the ability to fabricate nanoscale devices and materials with 
a high degree of precision and accuracy.  Reproducibility is of crucial importance to 
insure that device and material variation can be eliminated as a source of diagnostic 
variability.  All of the nanoscale biosensing devices and nanomaterials in this section are 
included based on their potential to significantly impact point-of-care diagnosis due to 
their high sensitivity and capacity for high throughput screening of biological samples.  
  
1.4.1 Nanowire Biosensors         
The field effect transistor (FET), the basic three terminal logic device found in 
almost all integrated circuits and which has been in development for over 50 years, can 
be fabricated using a number of different semiconductor materials, such as silicon, 
germanium, and gallium arsenide to name a few. This device can be configured as a 
sensor by eliminating the metal gating electrode and directly modifying the gate oxide 
with molecular receptors capable of binding to charged species of interest resulting in a 
direct change to the channel conductance.  [47] The FET channel conductance indicates 
the amount of current that can flow through the channel for a given bias voltage.  Boron-
doped silicon nanowires have been used to create extremely sensitive, real-time, 
electrically based sensors for the quantitative detection of biological species. [48] The 
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sensitivity of FETs whose active areas are comprised of nanowires is greatly enhanced 
over conventional bulk semiconductor FETs because of their small diameter, between 10 
nm and 20 nm, and high surface area to volume ratios, which allow for binding of  target 
molecules, causing accumulation or depletion of carriers throughout a much larger 
percentage of the channel cross-section. Furthermore, a very large percentage of the 
nanowire surface is available for functionalization with chemical or biological molecular 
recognition units that provide selective analyte detection. [49-51] Devices based on 
chemically functionalized or antigen-conjugated silicon nanowire have been 
demonstrated to successfully transduce biological binding events in real-time at 
sensitivities approaching 0.9 pg/mL.    
An interesting approach was based on the real-time, label-free, electrical detection 
of vascular endothelial growth factor (VEGF) for cancer diagnosis using an anti-VEGF 
aptamer-modified Si nanowire field-effect transistors (SiNW-FETs). In this system, the 
target VEGF molecules consistently act on the gate dielectrics and their recognition to the 
anti-VEGF aptamers induces changes in the detection currents. The detection limit for 
VEGFs in this study was determined as 104pM, a sensitivity threshold compatible with 
the natural concentration of this protein in blood. [52] To realize the considerable 
potential of sensors based on electrical detection, arrays of independent nanodevices must 
be fully integrated with on-chip computation and wireless communication. Nanowire 
assemblies with microchip technology is emphasized as a key step toward the ultimate 
goal of multiplexed detection at the point of care using portable, low power, electronic 
biosensor chips. [53] 
 20
1.4.2 Micro- and Nanocantilever Arrays 
Another promising area in diagnostic research emphasizes specific molecular 
recognition through the use of micro- and nanocantilevers, with the nomenclature 
indicating the length scale of the cantilever beam thickness (all other dimensions are 
usually microscale). One widely investigated architecture to realize this label free 
strategy is the micro- or nanocantilever, with the nomenclature indicating the length scale 
of the cantilever beam thickness. These micro- and nanocantilevers, which are usually 
microfabricated in silicon but can also be produced with piezoelectric material such as 
quartz, can operate either statically, by measuring absolute cantilever deflection, or 
dynamically, by measuring resonance frequency shifts. [54] Micro- and nanocantilevers, 
in addition to quantifying DNA hybridization with single base pair resolution, have used 
been to detect a variety of biomarkers using both the static [55] and dynamic [56] 
measurement modes. Through multiplexed testing using arrays of differentially 
functionalized cantilevers, this device architecture demonstrates great potential for high 
throughput protein screening, a crucial component for effective proteomic profiling.  
       
1.4.3 Magnetic Nanoparticles 
Magnetic nanoparticles, typically colloidal superparamagnetic iron oxides (SPIO), 
have been investigated as magnetic resonance imaging (MRI) contrast agents which have 
the attractive properties of being able to enhance the proton relaxation times of specific 
tissues and to be surface functionalized for targeted delivery. [57] The SPIO nanoparticles 
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are usually synthesized by an aqueous co-precipitation process, in which the pH value in the 
solution and the presence of surfactant coating materials play a predominant role in tuning the 
nanoparticle properties. [58] Typically, the magnetic nanoparticles are then chemically coated 
with various types of polymers to prevent nanoparticle aggregation and to imbue them with 
greater biological functionality. To significantly improve magnetic nanoparticles’ capability 
to detect and localize tumor, Zhang’s group have reported that the specific accumulation 
of CTX-targeted iron oxide nanoparticles in 9L glioma flank xenografts result in more 
thorough contrast enhancement of tumors in comparison to non-targeted control 
nanoparticles. [59] 
 
1.4.4 Quantum Dots  
Quantum dots consist of a semiconductor coreencapsulated by another 
semiconductor shell with a typical diameter of 2-10 nm. Due to their tunable nanoscale 
dimensions, high photostability, broad absorption spectra and narrow emission bands, 
quantum dots have been used as florescent labels to optically image a host of biological 
structures and processes ranging from DNA, small organelles, and tumors   to cell/cell 
interactions and cell signaling processes. [60-62] The quantum confinement effect allows 
for careful control of the emission properties of quantum dots by varying their size and 
material composition. [63] The fact that multiple quantum dots may be excited by a 
single excitation wavelength, thanks to their aforementioned broad absorption spectra, 
allows them to facilitate multiplexed diagnosis. [60, 64, 65] 
1.4.5 Gold Nanoparticles 
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Another promising nanomaterial for diagnostic applications is the gold 
nanoparticle.  These nanoscale constructs can be fabricated either as solid gold spherical 
nanoparticles with diameters in the range of 0.8nm to 250nm or as thin gold shells 
surrounding a dielectric core (i.e. silica). Au nanoparticles, unlike their quantum dot 
counter parts, do not emit light but only absorb it in a process called surface plasmon 
resonance (SPR). [66] This phenomenon describes a coherent oscillation of the surface 
conduction electrons excited by incident electromagnetic radiation. [67] This oscillation 
can only be sustained in materials that possess a complex dielectric constant with a 
negative real part and a slightly positive imaginary. The size and shape of the Au 
nanoparticles determine their optical resonance and can be tuned to achieve absorption in 
the mid infrared. [68, 69] The binding of Au nanoparticle-labeled entities to their 
respective targets leads to aggregation of the nanoparticles, resulting in a color change in 
the optical signal. [70] Furthermore, adsorption of target molecules on the surface of the 
Au nanoparticles causes changes to the local refractive index which can be measured as 
shifts in the plasmon frequency.  As a diagnostic tool, Au nanoparticles have been used 
to label DNA and proteins for detection of biological targets with enhanced sensitivity.  
 
1.4.6 Nanoparticle Based Bio-Bar Codes 
Methods for increasing the sensitivity and signal-to-noise ratio of clinically 
relevant assays by either directly amplifying low abundance targets, such as the 
replication of DNA and RNA sequences using polymerase chain reaction (PCR), or their 
corresponding optical or electronic signals have garnered considerable attention due to 
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their promising application towards biomarker screening and proteomic profiling. In 
2003, a nanoparticle-based bio-barcode method was developed for the ultrasensitive 
detection of proteins by Mirkin et al.. [71] This novel technique uses both a magnetic 
microparticle functionalized with one recognition element, which can be constituted of 
recognition molecules such as aptamers or antibodies, that specifically bind a target of 
interest and a gold nanoparticle conjugated by a similar second recognition element as 
well as large numbers of specific double stranded DNA sequences.  The two particles 
then sandwich and extract a specific target using a magnetic field. Whereas all of the 
magnetic microparticles are captured, only gold nanoparticles which have bonded to the 
target are captured.  The double-stranded DNA immobilized on the gold nanoparticle 
surface is then dehybridized to release one of the strands into solution, either chemically 
(dithiothreitol) [72] or thermally [73-75], and then experimentally detected using chip-
based DNA detection. The barcode assay possesses the potential for massive 
multiplexing through the simultaneous detection of a number of biological components in 
a single solution. The sensitivity of this methodology exceeds that of ELISA by up to 106, 
opening up the possibility for the use of low abundance biomarkers in diagnosis whose 
concentrations were considered too low to be useful with previous technologies.   
 
1.5 Conclusion 
The real-time, personalized and highly sensitive early stage diagnosis of disease 
remains an important challenge in modern medicine. With the ability to interact with 
matter at the nanoscale, the development of nanotechnology architectures and materials 
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could potentially extend subcellular and molecular detection beyond the limits of 
conventional diagnostic modalities.  At the very least, nanotechnology should be able to 
dramatically accelerate disease identification and biomarker discovery, as well as 
facilitate disease monitoring, especially of maladies presenting a high degree of 
molecular and compositional heterogeneity.   
Evidence is mounting that the low molecular-weight region of the circulatory 
proteome is a rich source of diagnostic biomarkers for the early detection of disease. This 
dissertation demonstrates that we have successfully fabricated a series of mesoporous 
silica thin films with a variety of nanophase morphologies and comprehensively explored 
their use in selectively capturing and enriching LMW peptides and proteins from human 
serum as well as their potential to provide simple and rapid sample collection, greatly 
reduced sample thresholds required for analysis and the ability to be produced at low 
cost. This proteomic profiling platform allows for efficient and flexible collection and 
analysis of the LMWP from human serum and should therefore prove quite useful in the 
fields of proteomic biomarker research and clinical proteomic assessment. The details 









AN OVERVIEW OF MESOPOROUS SILICA MATERIALS AND 
THEIR APPLICATION IN THE IMMOBILIZATION OF 
BIOMOLECULES 
 
2.1 Mesoporous Materials 
Porous materials have become attractive due to their ability to interact with atoms, 
ions and molecules not only at their surfaces, but throughout the bulk of the material. 
According to IUPAC definition, porous materials are classified into three classes 
depending on the predominant pore size: (1) microporous with the pore sizes below 2.0 
nm, (2) macroporous with pore sizes exceeding 50.0 nm, and (3) mesoporous with pore 
sizes between 2.0 and 50.0 nm. Since the exciting discovery of the first family of highly 
ordered mesoporous molecular sieves M41S by Mobil researchers in 1992 [76], many 
synthetic routes and strategies have been developed to yield a wide variety of porous 
materials with various chemical compositions and pore structures. Their applications in 
the fields of adsorption, catalysis, gas sensors, opto-electronic devices and drug delivery 
have been widely investigated because of their high surface areas, the precise variability 
of pore size and many other desirable properties.  
Long chain cationic surfactants were initially used as the template or pore forming 
agents to synthesize mesoporous materials with the hydrothermal sol-gel process. [77] 
However, the relatively small pore size restricts their use in separation, drug delivery and 
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catalytic process where large molecules are involved.  In middle of 1990s, the 
mesostructures prepared with a nonionic-surfactant-templating approach started attracting 
considerable attention. It is well known that self-assembly occurs when molecules 
interact with each other through a balance of attractive and repulsive interactions, such as 
van der Waals forces or hydrogen bonds. The introduction of nonionic surfactant 
provided a route to create mesoporous materials with the desired morphology. Hydrogen 
bonding interaction in self-assembly is significantly complementary to the rigid 
interaction between ionic surfactants and inorganic species. Depending on the selection 
of nonionic surfactant used as the template and varying synthesis conditions, this 
surfactant supermolecular templating approach has led to a breakthrough  allowing for  
the extension of porous materials into the meso-scale with relatively large, uniform and 
adjustable pore size. 
First reported by Pinnavaia and colleagues, mesoporous silicates were synthesized 
based on hydrogen-bonding interaction between the template of nonionic oligomeric 
surfactants and triblock copolymers under neutral conditions. In addition, there have been 
numerous efforts to determine the interaction between the silica surface and biomolecules 
due to their active saline group on the surface, mechanical strength and chemical 
inertness. The mesoporous silica combines the intrinsic physical and chemical properties 
of the inorganic or hybrid matrices with a highly defined nanoporous network which 
possesses tunable pore size and connectivity, high surface area and accessibility, and a 
specific orientation with respect to the substrate. In this dissertation, the application of the 
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mesoporous silica thin films in serum fractionation to selectively enrich the low 
molecular weight peptides and proteins will be demonstrated.  
 
2.2. Sol-gel Process 
The sol-gel process, a technique mainly based on inorganic polymerization 
reactions, has been widely used in the fields of materials science and ceramic engineering 
of high purity and homogeneity.[77-79] Typical precursors for sol-gel are metal 
alkoxides or metal chlorides, which undergo different forms of hydrolysis and 
polycondensation reactions. The formation of a metal oxide starts with connecting the 
metal centers with oxo (M-O-M) or hydroxo (M-OH-M) crosslink, then metal-oxo or 
metal-hydroxo polymers is generated in solution through the process of aging, drying, 
and densification. The general scheme can be represented in Figure 2.1 with silicone 
alkoxide as the example. [80] 
The hydrolysis and condensation reactions in the sol-gel process can be controlled 
by multiple parameters, such as the hydrolytic properties of the metal alkoxide, the ratio 
of solvent to  metal alkoxide, temperature, the addition of additive, and in particular, 
solution pH. By changing these experimental conditions, products with different 
morphologies, structures and surface chemistry can be obtained. In the case of silicon 
alkoxides, the rate of hydrolysis is higher than the rate of condensation when the 
experiment is run under an acidic environment. Normally the acid catalysis promotes the 
development of more linear or polymer-like molecules in the initial stages. On the other 
hand, base catalysis results in a higher condensation rate, tending to produce a dense-
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cluster growth or colloidal particular structure. [80] In addition, the activity of the alkoxy 
group can also influence the hydrolysis and condensation reactions based on a steric or 
leaving-group stability effect. For instance, tetramethoxysilane (TMOS) exhibits a more 
reactivity than tetraethoxysilane (TEOS). To meet the specific request in many 
applications, thin film can be fabricated by depositing sol-gel solution on a substrate (i.e. 
glass or silicon wafer) via spin-coating, dip-coating or other deposition techniques. After 
drying and heat-treatment, the "gel" is converted into dense ceramic or glass particles. In 
the next section, the detailed mechanism about the formation of mesoporous silica thin 
film will be discussed.  
 
Figure 2.1: The general scheme of sol-gel process of silicone alkoxide. Reprint with 
permission from Ref [80]. 
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The Sol-gel process is one of the most promising areas of material research. In 
particular, there is considerable potential for these materials in the fields of Separation 
and sensor technologies, since they combine mechanical strength, transparency in the 
visible spectrum, high porosity and surface area of gel-derived oxides. Sol-gel is also an 
effective method of fabrication and is extensively utilized to design and synthesize 
inorganic-organic hybrid materials with nanometer-scale architecture. As a result, these 
hybrid materials can find applications in many fields far beyond the scope of traditional 
composite materials.  
 
2.3 Nonionic Surfactants  
In a conventional pathway, sol-gel products synthesized without using a template 
normally result in microporous materials that are air dried (denoted as xerogels). 
numerous mesoporous or nanoporous silicate and other metal oxides with narrowly 
distributed pore diameters of 2-50 nm have been prepared through various synthetic 
routes and strategies containing a wide variety of materials and displaying various 
framework chemical compositions and pore structures. As discussed above, mesoporous 
materials prepared with neutral surfactants usually have improved stability and tunable 
physical properties. The main classes of nonionic surfactants for use as synthetic 
templates of mesoporous materials are oligomeric alkyl ethylene oxides, oligomeric 
alkylphenol ethylene oxides and amphiphilic block copolymers. Selecting a surfactant for 
the specific purpose is normally based on their hydrophilic/hydrophobic ratio, critical 
micelle concentration (CMC), hydrophile-lipophile balance (HLB), critical micelle 
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temperature (CMT) and cloud-point value (CPV). In our study, all triblock copolymers 
used were gifted from BASF Co.. Figure 2.2 shows a grid profile of triblock copolymers 
composed by (poly(ethylene oxide) (PEO)-poly(propylene oxide) (PPO)- poly(ethylene 
oxide) (PEO)) by plotting molecular weight ranges of the hydrophobe (PPO) against the 















Figure 2.2: Molecular weight ranges of the hydrophobe vs. the percentage of hydrophile 




Stucky and coworkers utilized commercial PEO-PPO-PEO tri-block copolymers 
under acidic condition to successfully synthesize a family of meoporous materials with 
varying ordered structures and a wide range of pore sizes, up to 30 nm. [81, 82] 
Compared to the conventionally used small molecular surfactants, the PEO-based 
amphiphilic copolymers exhibit  elegantly tunable phase behavior due to their block 
architecture and the weak hydrogen-bonding interaction between the phases of polymer 
and solvent, [83, 84] resulting in  diverse structural characteristics. Moreover, the PEO 
surfactants are neutral, nontoxic, and biodegradable. For the family of PEO-PPO-PEO tri-
block copolymers, at the given PPO block length, an increase in the PEO block is suitable 
to stabilize the ordered (e.g. cubic or hexagonal) mesostructures. [85]  
In our study, based on the molecular weight of the block copolymer and the ratio 
of the hydrophilic (PEO) to hydrophobic (PPO) chain length in the amphiphilic polymer, 
we selected four typical triblock copolymers: PEO5-PPO70-PEO5 (Pluronic L121), PEO20-
PPO70-PEO20 (Pluronic P123), PEO106-PPO70-PEO106 (Pluronic F127), PEO13-PPO30-
PEO13 (Pluronic L64). The hydrophilic/hydrophobic volume ratio (VH/VL) is suggested 
especially for nonionic-surfactant-templating systems to account for the formation of 
different mesophases. [86] The surfactants with high VH/VL ratios favor the formation of 
cage-like cubic mesoporous materials, whose topological curvatures are rather high. 
Block copolymers with medium hydrophilic/hydrophobic ratios usually direct the 
synthesis of mesostructures with medium curvatures (e.g. 2D hexagonal structure with 
space group of p6m or 3D bicontinuous cubic Ia3d). [87] 
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Furthermore, the advantage of certain high molecular weight block copolymers 
with is their ability to form a variety of structures by tuning experimental conditions 
during the synthesis of the mesoporous silica thin film. The concentration of block 
copolymers which affect the VH/VL ratios can also alter mesostructures. Normally, higher 
concentrations lead to mesostructures with lower mesophase curvature. [43, 88] The 
structural transformation of the mesoporous arrangement was carried out by tuning the 
concentration of the template polymer. Increasing the concentration of the template 
polymer resulted in a reduced interfacial curvature between the phases of the water, the 
copolymer, and the silicate, consequently initiating the interrelated progression from a 
spherical to a cylindrical structure. The details about controlling mesostructures will be 
described in the following section. 
 
2.4. Templated Mesoporous Thin Films 
2.4.1 Synthetic Mechanisms of Mesoporous Materials 
Although the synthetic mechanism of mesoporous silica thin films are still under 
discussion, two popular explanations have been proposed for describing nano-
organization of inorganic structures in the presence of nano-segregating surfactants as 
templating agents. The liquid-crystal templating (LCT) mechanism was first proposed by 
Beck etc. al. in 1992. [89-91] In this theory, the inorganic precursor condenses around a 
robust mesoframe formed by self-assembly of polymer surfactants. The second 
mechanism is cooperative self-assembly, in which surfactant molecules and inorganic 
species firstly assemble to form hybrid intermediate entities that behave as independent 
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composite hybrid species. Next these hybrid species, with the amphiphilic component, 
band together to form oligomeric building blocks with mesostructures. [92-94] However, 
we prefer to understanding it is a combined effect of both mechanisms that governs the 
construction of hybrid nanostructure. The starting materials and several critical 
experimental parameters play key roles in  determining which pathway is dominant in 
the synthetic procedure. This makes understanding the mechanisms of construction very 
difficult. The different chemical strategies for the synthesis of mesoporous materials are 












Figure 2.3: Chemical strategies for the synthesis of inorganic and hybrid mesoporous 
materials. Reprint with permission from Ref [95]. 
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          Route A corresponds to the coupling of molecules of sol-gel chemistry with 
polymer templating. The networks with mesotextures are obtained through the surfactant 
directed assembling of hydrolyzed inorganic precursors (i.e. silicate). high temperature, 
UV treatment or solvent extraction is able to achieve complete removal of organic 
template, as shown in route A1. Based on this pathway, the mesoporous materials can be 
further used in: 1. consolidation of the inorganic backbone (path A-1a), 2. templates to 
grow inorganic or organic nano-objects (path A-1b), 3. organic functionalization by 
alkoxysilanes (R′nSi(OR)4-n) (path A-2 or path A-1e) or with a post-grafting method 
(path A-1d), 4. cocondensation with metal alkoxides under surfactant directed assembly 
conditions (path A-3). On the other hand, strategies that combine surfactant directed 
assembling of presynthesized well-defined nanobuilding blocks have been also developed 
(route B).This approach uses precursors based on perfectly calibrated, preformed objects 
that preserve their integrity in the mesostructured templated hybrid phase (path B-1). The 
pathway that takes advantage of nanobuilding blocks exhibit several advantages 
including 1. potentially minimizing collapse problems that may be associated with 
template removal and crystallization, 2. exhibiting a lower hydrolytic reactivity,  3. 
possessing perfectly defined structures that facilitate the characterization of 
mesostructured hybrid phases and 4. allowing for a high control over structure. 
Alternative approachs based on the combination of path A and path B (path B-2) may be 
conceived to achieve further control in structure and function of mesoporous materials. 
 
2.4.2 Mesoporsous Silica Thin Films  
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The fabrication of mesoporous silica thin film were reported by Anderson et al., 
[96] Ogawa, [97] Ozin et al.,[98] and Brinker et al. [99] The application of anionic, 
cationic, or neutral surfactant led to  mesoporous materials with pore dimensions as a 
function of the chain length of the hydrophobic tail of the template and the headgroup 
size. The predominant methodology for the synthesis of mesoporous silica thin film is 
basedon evaporation-induced self-assembly (EISA). [99] Starting with homogeneous, 
hydro-alcoholic solutions of soluble silicate (i.e. TEOS) and a structure-directing 
polymer, the preferential evaporation of the solvent after dip or spin coating drives 
silica/copolymer self assembly into a uniform thin-film nanophase. With dip/spin coating, 
the precursor solution, strongly adhering to the substrate surface, is deposited in order to 
construct a homogeneous layer with specific final mesostructure. The solvent is 
evaporated under a controllable rate to prevent dewetting of the solution. Usually high 
surface tension solvents, such as water, lead to a nonhomogeneous covering, resulting in 
good adhesion between the substrate interface and the silica film. With progressive 
increases in concentration of template and inorganic precursors, the self-assembly is set 
up to attain a steady state in which the film composition is in equilibrium with its 
environment. Subsequent polycondensation relies on the consolidation of the inorganic 
network around the micelles and anchoring of the film at the substrate surface. The spin 
coating used in our study is slightly different from the other techniques in the sense that a 
small amount of solution is dropped at the center of the substrate.  In order to achieve a 
uniform coating, the solution is allowed to spread gently for a short time at a relatively 
slow spin speed. With a faster spin speed, the film is submitted to a shear force applied 
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between both interfaces of the drying solution layer as it is being formed. Mesoporous 
silica thin films with a narrow nano-scale pore size distribution and a high ratio of surface 
area to pore volume were formed after removing the organic template by calcination. 
 
2.5 Pore Dimension Control on Mesoporous Silica Thin Film 
2.5.1. Pore Size Control 
The topological design of mesoporous silica thin films with specific pore 
architecture and pore size has attracted interest from areas such as catalysis, adsorption, 
and host–guest chemistry. In the case of serum fractionation, the pore structure in 
mesoporous silica thin films as well as the pore size and porous network connectivity can 
play an important role in sample diffusion, serum separation and protein extraction. The 
pathways to control pore size include post-synthesis treatment [100-102]   and the use of 
surfactants of different chain lengths, triblock copolymers, [81, 103-106] and alkyl 
ethylene oxide as templates or swelling agents [107-110] in the formed micelles.  
As introduced in previous section, triblock copolymers were used in our study due 
to their capability to provide relatively large pore size. With these polymers as the 
synthetic template, pore characteristics of mesoporous products mainly depend on the 
molecular weight of copolymer, the ratio of the hydrophilic (PEO) to hydrophobic (PPO) 
chain length in the amphiphilic polymer and the proportion of the polymer in the starting 
material. [111]  It is easily understood that a polymer template with a higher hydrophobic 
volume facilitates greater pore size. We selected four typical triblock copolymers with 
different molecular weights and compositions: PEO5-PPO70-PEO5 (Pluronic L121), 
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PEO20-PPO70-PEO20 (Pluronic P123), PEO106-PPO70-PEO106 (Pluronic F127), PEO13-
PPO30-PEO13 (Pluronic L64). These were used as synthetic templates to form the 
mesoporous silica thin films with diversified structural and morphological properties. 
L121 is capable of forming the mesoporous silica thin film with the highest porosity and 
largest pore size as it has the highest hydrophobic to hydrophilic ratio among the pluronic 
surfactants. Furthermore, the addition of a hydrophobic polymer to the precursor solution 
modifies this ratio and enlarges the mesoporous silica pore size. In this study, Poly 
Propylene Glycol (PPG) was used as a swelling agent to extend pore size up to 7 nm and 
increase porosity to 67% for the thin film prepared with L121.  
2.5.2 Control of Pore Architecture 
2.5.2.1 Tunable Ordered Mesostructures 
Selection of the surfactant type and concentration allows for precise control over 
the resultant mesostructure. Highly ordered mesoporous materials can be synthesized by 
using nonionic surfactants with high molecular weight under acidic conditions.  It is 
believed that triblock copolymers not only play the role of a template but also insert into 
the silica framework with PEO blocks and form organic–inorganic hybrid frameworks. 
[112] In the case of the Pluronic F127 block copolymer, the periodic nanostructure can be 
transformed from a 3-dimensional (3D) cubic or a honeycomb-like hexagonal to a 2-
dimensional (2D) hexagonal framework by tuning the molar ratio of the copolymer to 
silicate precursor in solution.   
The exploration of the range of synthesis parameters reveals a special interplay 
between the main control variables: silicate/polymer molar ratio, the relative humidity 
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during and immediately after dip-coating, and the aging time prior to coating. [113, 114] 
The interaction between these variables is best understood in terms of the interfacial 
curvature between the hydrophilic and hydrophobic regions. For binary water-surfactant 
systems, the curvature at the hydrophilic/hydrophobic interface is intimately linked to the 
lyotropic liquid crystalline phase that self-assembles. A simple geometric theory based on 
a molecular packing parameter has been developed and is widely used to understand this 
relationship. The condensation parameter is mainly based on the nature of the 
amphiphilic copolymer, but the shape of the amphiphile is also very responsive to the 
environmental conditions such as polymer concentration, temperature, and the presence 
of other species.  
Hillhouse and his colleagues defined a parameter of g = V/lcAo, which is 
inversely related to the interfacial curvature at the hydrophilic/hydrophobic interface. 
Herein V is the volume of the hydrophobic tail, lc is the critical length of the hydrocarbon 
chain (which is roughly equal to but less than the fully extended length of the 
hydrocarbon chain), and Ao is an effective area of the head group at the 
hydrophilic/hydrophobic interface. For g = 1/3, cubic and 3D hexagonal lyotropic liquid 
crystals composed of packings of spherical micelles are expected. For g = 1/2, a 2D 
hexagonal phase composed of cylindrical micelles is expected. For g = 1, lamellar liquid 
crystals are expected. Estimating the parameter of self-assembly (or the curvature) from 
the surfactant framework and the environmental conditions in solution is quite 
complicated even for simple systems. [113, 114] For instance, for ionic surfactants the 
area of the head group is very dependent on the screening of head group charges, and 
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thus the area is particularly responsive to the ionic strength of the medium. For nonionic 
head groups, the area is also difficult to calculate because it depends on how the head 
group is solvated. It may be expanded or collapsed depending on the temperature and 
other environmental conditions, as is the case for ethylene oxide head groups. For the 
silica-nonionic surfactant systems, calculating accurate values of g or the curvature a 
priori is not possible. However, a geometric model which relates curvature with the final 
structure could be used as a paradigm to understand the systematic changes that occur as 
a result of altering composition or processing parameters in self-assembled 











Figure 2.4: EISA processing diagram showing the nanostructures obtained when the 
solutions are not aged for an extended duration (typically less than 2 h). Note 
the absence of the double-gyroid phase. Reprint with permission from Ref 
[113]. 
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          It has been shown that the relative volume fractions of the nonvolatile 
components in the coating solution are closely related to the interfacial curvature of the 
resulting mesostructure of films formed by EISA from nonionic surfactants. For a given 
surfactant, the volume fraction corresponding to a given phase was obtained from the 
binary aqueous-surfactant phase diagram. Alberius and co-workers [116] showed that the 
concentration of the inorganic precursor in an EISA coating solution needed to synthesize 
the same phase of the silica-surfactant thin film could be calculated. Thus, this “general 
predictive” method allows one to connect coating solution composition with the phase of 
the self-assembled film. However, it has been shown that relative humidity can play a 
dominant role in determining the phase, [120] and its effects are beyond the scope of the 
general predictive model as formulated. 
 
2.5.2.2 Disordered Mesostructures 
          The syntheses of disordered sponge-like or wormhole-like mesoporous silica 
materials templated by nonionic surfactants have also contributed a great deal to the 
employment of organization principles in the surfactant-templating approach. Although 
the mesostructure is disordered, it has uniform mesopores and and a high surface area. In 
particular, the pore sizes are very dependent on the synthesis temperature because 
hydrogen bonds between inorganic species and surfactants under neutral conditions are 
sensitive to temperature. [121] Disordered mesostructures have no unit cell, no 
symmetry, and no space group. However, characteristics such as uniformly sized pores, 
high surface area, and easy modulation open up possibilities in catalysis, adsorption, 
 41
separation and immobilization. For instance, the mesoporous silica thin films prepared by 
L121 and L64 exhibit a non-ordered mesostructure but possess a capability for protein 
recovery in a great mass range.  
 
2.6 Immobilization of Biomolecules in Mesoporous Silica 
Mesoporous silica materials have been considered to be ideal protein and peptide 
hosts due to their high adsorption capacity, good dispersibility in aqueous solution, and 
good compatibility with the surrounding environment. [122-127] Mesoporous structures 
with tunable pore sizes facilitate the effective size-selective adsorption of protein or 
peptide with different molecular weights based on the size-exclusion mechanism, [128, 
129] by which mesoporous silica is well suited for immobilization of biomolecules under 
room temperature (or low temperature) . The mesoporous silica showed high adsorption 
of cytochrome c, lyzozyme, myoglobin and β-lactoglobulin. Yet it had a low adsorption 
capacity for larger proteins (bovine serum albumin (BSA), ovalbumin and conalbumin) 
due to the pore exclusion effect. [130] 
Compared to other methods of immobilization, mesoporous materials have many 
advantages.  They   possess tunable physico-chemical properties, are thermally stable, 
are not photos-sensitive, have the potential to undergo a wide variety of chemical 
modifications, enable the stability of the encapsulated molecules, and preventing leaching 
of proteins due to the effective caging. 
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Cage-type ordered mesoporous silica patterns are ideal host matrices for 
immobilizing biomolecules, such as enzymes.  For enzyme immobilization inside 
mesoporous silica, pore size is an important factor. Generally small pores limit the 
diffusion of enzyme within the network of pores, while large pores increase the capability 
of mesoporous silica for enzyme immobilization. [130-133] Mesostructure plays another 
significant role in bioadsorption in terms of mass transfer and pore blocking. [134]  
  Chemical functionalization on the mesoporous silica surface is necessary for 
improving the conjugation of biomolecules with supporting material. Modified 
mesoporous silica has unique characteristics compared to the pure silica and has wider 
applications including ion exchange, catalysis, and gas separation. [135] In addition, 
functionalized mesoporous silica shows a higher capacity to immobilize the specific 
protein compared to pure silica. The organosilanes with amine functionality have 
received significant attention because of their wide range of applications, such as 
heterogeneous base catalysis, toxic arsenate ion trapping, support for metallic 
nanoparticles, sensors, and enzyme immobilization. [136] For the serum fractionation on 
mesoporous silica thin films investigated in this study, we focus on the recovery of 
specific proteins affected by the chemical modification on the mesoporous silica surface.  
Beside amine functionality, carboxyl groups and some other negative functional moieties 
are also conjugated with mesoporous silica thin films and their effect on harvesting the 





PREPARATION OF SURFACTANT-TEMPLATED MESOPOROUS 
SILICA THIN FILMS FOR ON-CHIP SERUM FRACTIONATION 
3.1 Introduction 
Mesoporous silica thin film made by self-assembly of the triblock copolymer 
(poly(ethylene oxide) (PEO)-poly(propylene oxide) (PPO)- poly(ethylene oxide) (PEO)) 
with hydrolyzed silicate precursors has generated substantial interest in the past ten years. 
[42, 43, 95, 111] With the integration of hydrogen bonding interaction at the 
organic/inorganic interface, ordered/unordered mesoporous silica thin films with desired 
and tunable physico-chemical properties have been widely investigated. Different 
mesoporous materials have been investigated in applications such as high surface area 
catalysis [137-139], molecular sieves [140, 141], gas sensors [142], opto-electronic 
devices [143, 144] and drug delivery [124, 145, 146]. As mentioned in the last chapter, 
mesoporous silica has been extensively studied for the absorption and separation of 
biological molecules due to their well defined pore network and surface reactivity. [146] 
The identification of circulating biomarkers holds great potential for non-invasive 
approaches in early diagnosis and prognosis, as well as for the monitoring of therapeutic 
efficiency. [31, 32, 40, 41, 147] In Chapter 1, we described that the circulating low 
molecular weight proteome (LMWP), composed of small proteins shed from tissues and 
cells or peptide fragments derived from the proteolytic degradation of larger proteins, has 
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been associated with the pathological condition in patients and likely reflects the state of 
disease. [35-37] 
In previous literature, we have demonstrated the use of mesoporous silica surfaces 
as substrates for the easy and rapid fractionation of small proteins and peptides. [4, 11, 
44, 45] In this dissertation, mesoporous silica thin films with tunable features at the 
nanoscale were fabricated with the aim of specifically harvesting the low molecular 
weight peptides and proteins from human serum. Using different polymer templates and 
polymer concentrations in the precursor solution, various pore size distributions, pore 
structures and surface hydrophilicities were determined and applied for morphology-
selective recovery of low mass proteins. With the assistance of mass spectrometry and 
statistic analysis, we are able to demonstrate the correlation between the nanophase 
characteristics of the mesoporous silica thin film and the specificity and efficacy of low 
mass proteome harvesting. In the present study, we employed advanced materials science 
and engineering techniques to design and characterize mesoporous silica thin films for 
efficient and selective harvesting of LMW peptides and proteins from human serum.  
       The formation mechanism of mesoporous silica thin films has been throughout 
discussed on Chapter 2. One of the promising characteristics of mesoporous silica thin 
films is the variety of achievable pore morphologies. Pore structure as well as pore size 
and porous network connectivity can play an important role in sample diffusion, serum 
separation and protein extraction. In mesoporous silica, pore characteristics mainly 
depend on the molecular weight of the block copolymer, the ratio of the hydrophilic 
(PEO) to hydrophobic (PPO) chain length in the amphiphilic polymer and the proportion 
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of the polymer in the starting material. Triblock copolymers PEO5-PPO70-PEO5 (Pluronic 
L121), PEO20-PPO70-PEO20 (Pluronic P123), PEO106-PPO70-PEO106 (Pluronic F127), 
PEO13-PPO30-PEO13 (Pluronic L64) were used as the synthetic templates to form the 
mesoporous silica thin films with diversified structural and morphological properties. 
L121 is capable of forming the mesoporous silica thin film with the highest porosity and 
largest pore size as it has the highest hydrophobic to hydrophilic ratio among the pluronic 
surfactants. Furthermore, the addition of a hydrophobic polymer to the precursor solution 
modifies this ratio and thus enlarges the mesoporous silica pore size. In this study, Poly 
Propylene Glycol (PPG) was used as a swelling agent to extend pore size up to 7 nm and 
increase porosity to 67% for the thin film prepared with L121. Using Pluronic F127 block 
copolymer, the periodic nanostructure can be transformed from a 3-dimensional (3D) 
cubic or a honeycomb-like hexagonal to a 2-dimensional (2D) hexagonal framework by 
tuning the amount of the copolymer in solution.  In addition, ionic surfactant 
(cetyltrimethylammonium bromide: CTAB) was used to prepare the microporous silica 
thin film with much smaller pore size (~ 2nm) to study the efficacy of molecular cut-off 
of protein recovery depending on a wide range of pore size distributions.  
 
3.2 Experimental Section 
3.2.1. Materials 
Tetraethyl orthosilicate (TEOS) and cetyl trimethylammonium bromide (CTAB) 
were purchased from Aldrich Chemicals (Milwaukee, WI). Ethanol and HCl was 
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purchased from Fisher Scientific (Fair Lawn, NJ). Nonionic surfactants (F127, P123, 
L121 and L64) were gifted from BASF Co.. All chemicals and reagents were used as 
received without further purification. 
 
3.2.2 Preparation of mesoporous silica thin films 
As listed in Table 1, the molar ratios of starting materials are slightly different for 
various surfactants. The typical preparation of precursor solution is shown in Figure 3.1 
and was carried out as follows:  30 ml of TEOS was dissolved in the mixture of 48 ml of 
ethanol, 20 ml of distilled water, and 3 ml of 2 M HCl and stirred for 1 hour at 75°C to 
form a clear silicate sol. Separately, a portion of different surfactant (1.0g of CTAB, 1.5g 
of F127, 1.2g of L64, 1.6g of P123 or 1.2g of L121) was responsively dissolved in 10 ml 
of ethanol by stirring at room temperature. In the case of using L121 as template, 0.6g or 
1.2g of PPG solution was dropped into the L121 solution with vigorous stirring at room 
temperature. 10 ml of hydrolyzed silicate sol was dropped into the triblock co-polymer 
solution followed by stirring for 2 hrs at room temperature. The coating sol was spin-
coated on a Si (1 0 0) wafter for 25 seconds at the spin rate of 750 rpm for the solution 
containing CTAB, 1500 rpm for the solution with F127 or P123 and 2500 rpm for the 
mixture with L64, L121 or L121+PPG. The as-deposited films were heated at 80 °C for 
24 hrs to increase the degree of polymerization of the silica framework and to further 
enhance their thermal stability. The temperature was raised at a rate of 1°C per min, and 
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the chips was heated at 425°C for 5 h to remove the organic surfactant. The films 
produced were transparent and crackless. 
 
a. Formation of Polymer Template 
 
                             
b. Formation of Mesoporous Silica Thin Films 
 
 
Figure 3.1: The procedure of synthesizing a mesoporous silica thin film. a. The 
micellization of polymer template in solution, b. the formation of 
mesoporous silica thin films by spin-coating and calcination. 
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3.2.3 Characterization and instrumentation 
Mesostructured thin films are normally composed of a very small amount of 
matter (usually between 10 and 500 μg/cm2 of film) spread onto a substrate. This fact 
makes their characterization more difficult than that of bulk materials and limited to 
spectroscopic investigations and other common techniques. We utilized several 
characterization techniques to study the spin-coated mesoporous silica thin fims.  
 
3.2.3.1 Ellipsometry 
Ellipsometry measures the change of polarization upon reflection or transmission. 
The nature of the polarization change is determined by the sample's properties (thickness, 
complex refractive index or dielectric function tensor). (www.wikipedia.com) In our 
study, by carrying out with a variable angle spectroscopic ellipsometer (J. A. Woollam 
Co. M-2000DI) and modeling with WVASE32 software, the thickness of thin films and 
their porosities were measured respectively in Cauchy model and Effective Medium 
Approximation (EMA) model. Ellipsometric optical quantities, the phase (Δ), and 
amplitude (ψ) were carried by requiring spectra for 65◦, 70◦, and 75◦ incidence angles 
using wavelengths from 300 to 1800 nm. Ellipsometry is an indirect method, i.e., in 
general the measured ψ and Δ cannot be converted directly into the optical constants of 
the sample. Normally, a layer model must be established, which considers the optical 
constants (refractive index or dielectric function tensor) and thickness parameters of all 
individual layers of the sample including the correct layer sequence. The calculated ψ and 
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Δ values that match the experimental data best provide the optical constants and thickness 
parameters of the sample. 
Therefore, in the Cauchy model, the top layer’s thickness, reflective index, and 
model fit parameters An, Bn and Cn were determined by fitting experimental data with the 
model and minimizing the mean square error (usually less than 20). While using the 
EMA model, the films’ porosities were calculated by assuming a certain volume of void 
in the pure silica and setting the top layer’s thickness obtained by the Cauchy model as 
constant.  
 
3.2.3.2 1D X-ray Diffraction 
X-ray diffraction (XRD) is a technique using X-ray scattering on microcrystalline 
samples for the structural characterization of materials. It is based on the elastic scattering 
of electromagnetic waves on lattice planes, or more precisely at the electronic shells of 
regularly arranged atoms. Ideally, every possible crystalline orientation is represented 
equally in a powdered sample. The Bragg equation is a simple method to determine the 
distance d of lattice planes. To derive the Bragg equation one considers the lattice planes 
of a crystal as semitransparent mirrors partly reflecting an incoming beam (Fig. 3.2).  
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Figure 3.2: Scheme of construct the Bragg equation.  
 
For a monochromatic beam the reflected rays interfere constructively or 
destructively depending on the angle of incidence θ and the lattice diameter d. Two 
reflected monochromatic beams interfere if the path difference is an integer multiple of 
the wavelength λ. This results in the Bragg equation for constructive interference: 
 
  　　               nλ=2dsinθ  with 　 n = 1, 2, 3, …       Eq. 3.1　　  
 
When the scattered radiation is collected on a flat plate detector the averaging due 
to random orientations of the particles leads to smooth diffraction rings around the beam 
axis rather than the discrete Laue spots as observed for single crystal diffraction. The 
angle between the beam axis and the ring is called the scattering angle and in x-ray 
crystallography denoted as 2θ. 
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To investigate the mesostructure of porous silica thin film and determine their 
periodicity, XRD pattern scanned at small angle range (typically 0.2◦ to 10◦) is carried 
out. Because this angular range contains information about the shape and size of 
molecules at nano-scale, characteristic distances of partially ordered materials, pore sizes, 
and other data. Small angle XRD is capable of delivering structural information of 
macromolecules between 5 and 25 nm, and of repeat distances in partially ordered 
systems of up to 150 nm. [148] In this study, X-ray diffraction (XRD) patterns were 
obtained on Philips X’Pert-MPD system with Cu Kα ray (45 kV, 40mA). θ-2θ scanning 
were recorded from all spin-coated films at 1s/0.001◦ step over the angle range from 0.2◦ 
to 6◦.  
 
3.2.3.3 X-ray photoelectron spectroscopy (XPS) 
XPS is defined as a quantitative spectroscopic technique that measures the 
elemental composition, empirical formula, chemical state and electronic state of the 
elements of a material. XPS spectra are obtained by irradiating a material with a beam of 
X-rays while simultaneously measuring the kinetic energy and number of electrons that 
escape from the top 1 to 10 nm of the material being analyzed. XPS is a surface chemical 
analysis technique that can be used to analyze the surface chemistry of a material in its 




Figure 3.3: Basic components of a monochromatic XPS system. (The Author, the 
copyright holder of this work, releases it into the public domain. This 
applies worldwide. He/she grants any entity the right to use this work for 
any purpose, without any conditions, unless such conditions are required by 
law. (http://www.wikipedia.com)) 
 
In our study, the chemical composition or the purity of mesoporous silica thin 
film was determined by XPS spectra, which were recorded using a X-ray photoelectron 
spectrometer (Kratos Axis Ultra), utilizing a monochromated Al-K　 X-ray source (h  = 　
1486.5 eV), hydrid optics (employing a magnetic and electrostatic lens simultaneously) 
and a multi-channel plate and delay line detector coupled to a hemispherical analyzer.  
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The photoelectrons' take off angle was 90 . All spectra were recorded using an aperture 　
slot of 300x700 microns, and high resolution spectra were collected with a pass energy of 
20 eV.  The pressure in the analysis chamber was typically 2x10-9 Torr during data 
acquisition. Kratos XPS analysis software was used to determine the stoichiometry of 
samples from corrected peak areas and employed Kratos sensitivity factors for each 
element of interest.       
 
3.2.3.4 Transmission Electron Microscopy (TEM) 
TEM is a microscopy technique whereby a beam of electrons is transmitted 
through an ultra thin specimen, interacting with the specimen as it passes through. An 
image is formed from the interaction of the electrons transmitted through the specimen; 
the image is magnified and focused onto an imaging device, such as a fluorescent screen, 
on a layer of photographic film. Transmission electron microscopy (TEM; FEI Technai; 
FEI Co.) was used in acquiring micrographs of the plant view of mesoporous silica thin 
films at high tension of 200 kV. The TEM sample was prepared by dipping an ethanol 
suspension of the finely ground sol-gel onto a Cu grid coated with a holey C film. 
 
3.2.3.5 Gas Adsorption/Desorption Isotherm 
Porous texture can be described by gas adsorption/desorption isotherms. Many 
applications involving porous films are critically dependent on accurate knowledge of the 
pore size distribution (PSD), pore connectivity of the network, and the ability to 
determine matter exchange and matter adsorption capacities of the porous network and 
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the film environment. By analyzing the multilayer physisorption and capillary 
condensation of a gas within the pores, a plot of the adsorbed volume of gas versus the 
partial pressure P/P0 of gas is obtained. The mono- and multilayer physisorption of the 
gas observed at low P/P0 can be plotted by the Brunauer-Emmett-Teller (BET) 
equationEq. 3.2 and allows the determination of the surface area, with nm being the 
number of molecules needed to cover the accessible surface with a monolayer of 
molecules, n, the number of molecules adsorbed at the partial pressure P/P0, and C, a 
parameter characteristic of the net heat of adsorption of the molecule at the surface. [149, 
150]                                                                                                        
 
                                                                    Eq. 3.2 
 
The gas uptake observed at higher P/P0 values, characteristic of capillary 
condensation, is used for the determination of the pore size distribution between 2 and 50 
nm via the Kelvin equation(Eq. 3.3) that describes the condition of appearance of the 
capillary condensation at a given value of P/P0, with γ, the condensed liquid surface 
tension, VL the molar volume of the liquid adsorbate, rP the radius of the pore, and G, a 
geometrical factor characteristic of the liquid-air meniscus curvature. [151] 
 
                                                                          Eq. 3.3 
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       To determine the pore size distribution, pore volume and surface area of 
mesoporous silica thin films we prepared, Quantachrome was used to record the N2 
adsorption/desorption isotherm at 77 K on the full range of relative P/P0 pressures.  BET 
surface areas were determined over a relative pressure range of 0.05 to 0.3. Nanopore 
size distributions were calculated from the desorption branch of the isotherms using the 
Barrett-Joyner-Halenda (BJH) method. 
 
3.2.3.6 Contact Angles 
The contact angle is the angle at which the liquid/vapor interface meets the surface. 
The concept is most often illustrated with a small liquid droplet resting on a flat 
horizontal solid surface. Contact angle is measured using a contact angle goniometer. If 
the liquid is very strongly attracted to the solid surface (for example water on a strongly 
hydrophilic solid) the droplet will completely spread out on the solid surface and the 
contact angle will be close to 0°. Less strongly hydrophilic solids will have a contact 
angle up to 90°. On many highly hydrophilic surfaces, water droplets will exhibit contact 
angles of 0° to 30°. If the solid surface is hydrophobic, the contact angle will be larger 
than 90°. Highly hydrophobic surfaces have water contact angles as high as 150° or even 
nearly 180°. On these surfaces, water droplets simply rest on the surface, without actually 
wetting to any significant extent. In our study, contact angles of film surface were 
measured by goniometer with captive bubble contact angle measurement.  
 
3.3 Results and Discussions 
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Most of the procedures used for the synthesis of mesoporous silica films are 
similar to the ones described by Zhao et. al..[43] The primary objective of this study was 
to tailor mesoporous silica thin film pore morphology and internal structure by adjusting 
synthetic parameters and to explore their efficacy for the specific harvesting of LMWP 
species from human serum. A consistent proteomic profiling approach requires that the 
mesoporous silica-based serum fractionation be performed with a well-defined high 
purity substrate possessing thermal stability as well as uniform nanostructure and film 
thickness throughout the entire mesoporous silica layer. Preparation of the precursor 
solution, which involves the cooperative assembly of a polymer surfactant and soluble 
silicate species, plays a dominant role in determining the molecular organization of the 
final product. The molar ratios of starting materials are listed in Table 3.1 for each block 
copolymer used.  
Thickness is the primary characteristic of a thin layer. Parameters controlling the 
thickness vary with techniques (i.e. dip-coating, spin-coating or spray coating), the time 
for diffusion, and the quantity and the concentration of the deposited solution. In this 
study, for a given molar ratio of silicate to polymer in solution, the porous films’ 
thickness was restricted from 700 ~ 900 nm for the purposes of avoiding shrinkage  
while maintaining  enough pore volume in the unit area for sample diffusion by tuning 
the polymer concentration. This was accomplished by maintaining the molar ratio of 
ethanol to silicate to between 12 and 14 and water to silicate at less than 6. For all 
precursor solutions we prepared, the pH was controlled at 1.5 to prevent the precipitation 
of nanoporous silicate corresponding to the isoelectric point of orthosilicic acid, as well 
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as to balance the procedure between the silicate hydrolysis and condensation of 
hydrolyzed silicate to polymer micelle. Based on previous literature [111], when the pH 
value is in the range from 1 to 2, the precipitation of mesoporous silicates is extremely 
slow, probably corresponding to the isoelectric point of orthosilicic acid. 
 
Table 3.1: Molar ratio of starting materials to fabricate nanoporous silica thin films with 
different template polymers and their physical properties calculated by 




Porosity, normally generated from the hydrophobic part of triblock copolymers, 
was adjusted by changing the molar ratio of the polymers to silicate precursor in the 
mixture, regardless of the concentration of polymer template in the solution. Spin 
coating, superior to other deposition techniques for achieving uniform thickness and 
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porosity, was used to form the mesoporous silica thin films on a silicon substrate.  The 
substrates were then cleaved to produce chips for quantitative proteomics analysis.  
Previous literature has demonstrated that mesoporous silica products can exhibit 
substantial non-uniformity as a result of inadequately controlled synthesis due to the 
weak interaction between molecules during the self-assembly process. [111] Other 
experimental parameters, such as aging time of the precursor solution, coating speed 
during solution deposition, and calcination temperature were studied to understand their 
impact on the final features of the mesoporous structure. To reduce experimental 
complexity, only the amphiphilic structure of the block co-polymers and their 
concentration in the precursor solution were adjusted, with all other process parameters 
held constant, to investigate their effect on pore geometry and morphology.  
To characterize the pore architecture and physico-chemical properties of 
mesoporous silica thin films, various techniques were employed, including ellipsometry, 
1-dimentional X-ray diffraction (1D-XRD), N2 adsorption/desorption, transmission 
electron microscopy (TEM),  X-ray photoelectron spectroscopy (XPS) and surface 
contact angle goniometry. Figure 3.4 depicts the overall purity and the atomic silicon-to-
oxygen ratio of the mesoporous silica thin films prepared with L121 as the structure-
directing template as determined by XPS using the Si2p, O1s and C1s regions of the 
spectra. The very weak signal for the C1s region can be attributed to minimal 
contamination (i.e. hydrocarbons) on the film surface. Both the Si2p and O1s regions 
consisted of a sharp and symmetric single peak at binding energies around 101.4 eV and 
530.7 eV respectively, which strongly point to a silica framework with high 
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condensation. By calculating the areas under the peaks for Si2p and O1s, an atomic 
silicon-to-oxygen ratio of 1:2.004 was obtained to further confirm the high purity of 
mesoporous silica thin films. Similar XPS results were acquired for mesoporous silica 
thin films synthesized using the alternative polymer templates.  
 
Figure 3.4: The purity of Mesoporous Silica thin films. XPS core level spectra used to 
analyze the relative amounts of C, Si, and O on the surface of a mesoporous 
silica thin film prepared from Pluronic L121. The tabulated atomic 
concentration of each element is shown in the lower right.  
 
3.3.1 Ionic Surfactant vs. Nonionic Surfactants 
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To obtain the various pore sizes required to harvest the specific proteome from 
serum based on size-exclusion, the polymer templates in this section were chosen from 
both ionic surfactant (cetyltrimethylammonium bromide: CTAB) and non-ionic triblock 
copolymers (PEO106-PPO70-PEO106 : Pluronic F127, PEO5-PPO70-PEO5: Pluronic L121). 
Using low molecular weight surfactant directing agent, such as CTAB, the resulting 
nanoporous silica thin film will possess a smaller average pore size than the films 
prepared with F127 and L121, which have much higher molecular weight and provide a 
controlled pathway for the preparation of large-pore silicate nanostructure. Herein, 
nanoporous silica thin films were first examined by X-ray diffraction (XRD to display the 
periodicity and the organization of pore’s nanostructure prepared with CTAB, F127, 
L121+PPG (with molar ratio of 1:0.5), as shown in Figure 3.5.  The XRD pattern in 
Figure 3.5.a showed nanoporous silica thin film prepared by CTAB on a silicon (1 0 0) 
substrate. The appearance of the peak for (200) reflection at 2.20◦ of 2θ with d200=3.16 
nm indicated that the periodic 3D cubic structure of silica nano-composite formed along 
the surface of substrate after calcination at 425◦C.  In figure 3.5.b, the XRD pattern of 
coating prepared with F127 exhibited an ordered nanoporous texture based on the highly 
intense (100) reflection peak at 2θ=0.99° (d100=9.01nm). The lower intensity peaked at 
(110) with d110=6.30nm and (200) with d200=4.75nm indicated the formation of a 3D 
honeycomb-like nanostructure. In Figure 3.5.c the XRD patterns for those fabricated by 
L121 displayed a curve in the small angle range with the appearance of a peak, 
consequentlyillustrating the formation of disordered nanopores. Transmission electron 
microscopy (TEM) analysis was performed on the plane view, which was inserted below 
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with the XRD diagram of nanoporous silica thin film prepared by each polymer template.  
The TEM image confirms the conclusion regarding the identification of the ordering and 
nanostructure of the thin film which was postulated with the XRD patterns. 
 
Figure 3.5: 1D XRD patterns and TEM image of plane-view (inserted) for mesoporous 




        N2 adsorption-desorption measurements were conducted to determine the 
entrance pore size distribution and surface area of mesoporous silica thin films prepared 
by three different polymers. In Figure 3.6, the BJH pore size distributions for chips 
prepared by CTAB (Fig.3.6.a), F127 (Fig.3.6.b), and L121+PPG (Fig. 3.6.c) were 
provided with their adsorption-desorption isotherms inserted. Due to the small pore size 
(2.01 nm) on the nanoporous silica thin film synthesized by CTAB, its sorption isotherm 
was Type II displaying a H1 hysteresis loop. All adsorption/desorption isotherms carried 
by chips prepared by non-ionic surfactants were Type IV with a well-defined H2 
hysteresis loop. In these figures, the inflection points appeared at 0.30 ≤ P/P0 ≤ 0.80 , 
which indicated the formation of ink-bottle shape nanopores. All their BJH pore size 
distributions exhibited sharp peaks, which suggested that both periodic and non-ordered 
nanophase were created on the chips with uniform pore size.  
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Figure 3.6: Pore size distribution from BJH adsorption for mesoporous silica thin films 
prepared using a. CTAB, b. F127 and c. L121+50%PPG. The corresponding 






3.3.2 Control on Pore Structure and Distributional Architecture 
         One main advantage of block copolymers with high molecular weight, in 
comparison to those of low molecular weight, is their ability to form a variety of 
structures by tuning experimental conditions during mesoporous silica thin film 
synthesis. The structural transformation of the mesoporous arrangement was carried out 
by tuning the concentration of the template polymer. Increasing the concentration of the 
template polymer resulted in a reduced interfacial curvature between the phases of the 
water, the copolymer, and the silicate, consequently initiating the interrelated progression 
from a spherical to a cylindrical structure. Pluronic F127, with its high molecular weight, 
possesses this high degree of structural periodicity. In this study, the concentrations of all 
starting materials, except F127, were kept constant. Figure 3.7 demonstrates the changes 
in the nanostructure of the mesoporous silica by characterization through XRD pattern,. 
When the F127 concentration in the precursor solution was kept at 4.0×10-3 M, the final 
mesoporous silica thin film acquired a 3D cubic structure with reflection peaks at (100) 
and (110) and a low intensity peak at (220) as indicated by the XRD pattern (Fig.3.7.a) 
and further verified through TEM imaging  (inset of Fig. 3.7.b). Increasing the F127 
concentration to 6.0×10-3 M yields a 3D honeycomb like nanostructure hexagonally 
arranged on the substrate, as confirmed by XRD, with peaks at (200) and (400) (Fig. 
3.7.c), and TEM (Fig.3.7.d). A further increase of the F127 concentration to 8.0×10-3 M 
resulted in a 2D hexagonal nanostructure parallel to the substrate surface.  The sharp 
peaks at (100) and (300) in the XRD pattern (Fig. 3.7.e) and TEM imaging (Fig.3.7.f) 
confirm this conclusion. As we discussed in the last chapter, the structural transformation 
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of mesoporous silica can be tuned by changing the interfacial curvature between the 
phases of polymer-silicate-hydrophilic solvent.  
 
Figure 3.7: The physical characterizations of mesoporous silica thin films. XRD patterns 
(a, c, e), TEM (inset b, d, f) for the structural transformation of mesoporous 
thin films prepared using Pluronic F127 at different concentrations in the 




N2 adsorption/desorption curves were generated using a Quantachrome Autosorb-
3b BET Surface Analyzer and the pore size distribution was calculated using the Barrett-
Joyner-Halenda (BJH) method. In Figure 3.8.a, the adsorption/desorption isotherms 
describe a Type IV isotherm with a H2 hysteresis loop (sloping adsorption branch and 
nearly vertical desorption branch), indicating a nanoporous structure with interconnecting 
channels. Inflection points appearing at 0.40 ≤ P/P0 ≤ 0.75 indicated the formation of ink-
bottle shape nanopores. Increasing the F127 concentration to 6.0×10-3 M yields a 3D 
honeycomb like nanostructure hexagonally arranged on the substrate, as confirmed by the 
previous figure. The adsorption/desorption isotherms, depicted with the pore size 
distribution in the inset of Figure 3.8.b, vary slightly from the similar adsorption-
desorption Type VI isotherms described for the lower concentration F127 mesoporous 
silica thin films due to the increased internal pore connectivity. A further increase of the 
F127 concentration to 8.0×10-3 M resulted in a 2D hexagonal nanostructure parallel to the 
substrate surface.  The adsorption/desorption isotherms (Fig. 3.8.c inset) displays a 
narrow hysteresis loop indicating significantly less inter-pore connectivity than either of 
the previous two mesoporous silica thin film morphologies. The similar pore size 
distributions of the 3 different nanostructures, with average pore sizes around 3.7 nm, 
illustrate that the change of pore size was minimally dependent on the molar ratios of the 
starting materials.  
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Figure 3.8: N2 adsorption/desorption analysis (pore size distribution, isotherms in the 
insets), of the structural transformation of mesoporous thin films prepared 
using Pluronic F127 at different concentrations in the precursor solution: 






3.3.3 Application of Different Types of Nonionic Surfactants 
3.3.3.1 Effect on Pore Structures of Mesoporous Silica 
Another factor that influences the interfacial curvature between the polymer and 
the other solution components (TEOS, water, etc.), and thus determines the nanostructure 
and the pore size, is the hydrophilic/hydrophobic volume ratio of the copolymer. A series 
of tri-block copolymers with different hydrophobic (PPO) to hydrophilic (PEO) volume 
ratios were selected to synthesize the mesoporous silica thin films with different pore 
sizes and morphologies and subsequently investigated for their LMWP harvesting 
efficacy. Block copolymer compositions with longer PPO block lengths lead to increased 
pore size.  Longer PEO block lengths for a given PPO block length (L121 versus P123 
versus F127) lead to the formation of more highly ordered periodic nanostructures. [4] L-
type (liquid phase) block copolymers (such as L64 and L121) with lower PEO block 
lengths offer increased porosity due to their greater deforming performance but more 
chaotic nanostructure. Figure 3.9 displays XRD patterns for mesoporous silica thin films 
prepared from P123, F127, L64 and L121+PPG (with molar ratio of 1:0.5) detailing their 
internal nanoscale organization. In the spectra for the mesoporous silica thin film 
prepared with P123 (molar ratio P123/TEOS = 5.9×10-3) (Figure 3.9.a), the appearance of 
an intense and narrow peak for the (200) reflection at 1.66◦ of 2θ and d200=5.31 nm 
combined with a lower intensity (310) peak at 2θ=2.99° indicate the formation of a 
hexagonally arranged periodic silica nano-composite thin film after calcination at 425◦C.  
The absence of the (110) reflection indicates that the (100) plane of the 2D hexagonal 
unit cell was parallel to the surface of the silicon substrate. The mesoporous silica thin 
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film prepared with F127 (Figure 3.9.b) (molar ratio F127/TEOS = 1.13×10-2) also 
exhibits an ordered nanoporous morphology indicated by the highly intense (100) 
reflection peak at 2θ=0.99° (d100=8.89nm). The lower intensity peaked at (110) with 
d110=6.27nm and (200) with d200=4.80nm points to the formation of a 3D honeycomb-like 
hexagonal nanostructure. The XRD patterns for those fabricated by L-type block 
copolymers are shown in Figure 3.9.c (for L64) and 3.9.d (for L121 with PPG).  Their 
low intensity and broad peaks in the small angle region were caused by the formation of 
unordered worm-like nanopores. 
 
Figure 3.9: XRD patterns of nanoporous silica thin films prepared using (a) P123, (b) 




Figure 3.10: STEM images for plant view of nanoporous silica chips made by different 
surfactants with certain molar ratio of TEOS/surfactant. a. P123 at 
P123/TEOS = 9.4×10-3, b. F127 at F127/TEOS = 9.4×10-3, c. L64 at 
L64/TEOS=4.14×10-2, d. L121 at L121/TEOS = 1.09×10-2. 
 
Scanning transmission electron microscopy (STEM) analysis was performed on 
the plane view of mesoporous silica thin films. Figure 3.10 displays plane-view images of 
mesoporous silica thin films prepared with different copolymers under various 
experimental conditions. As shown in Figure 3.10.a, 2D-hexagonal nanostructure was 
formed with porous silica thin film prepared with P123 as template  with the molar ratio 
of P123/TEOS = 5.9×10-3 at a  pH value of 1.38 in precursor solution. Figure 3.10.b 
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displays a 3D cubic nanostructure formed by F127 as template with a molar ratio of 
TEOS/F127 is 9.4×10-3. As discussed above, a copolymer with a higher ratio of 
hydrophilic/hydrophobic chains that prefers to form an ordered nanoporous structure 
(such as P123 and F127), while L-type block copolymer (Pluronic L64 or L121) cannot 
provide periodic nanotexture with silicate. Figure 3.10.c and d are the STEM images of 
the top view of mesoporous silica thin film prepared with L64 and L121. With the short 
hydrophobic chain (PPO), the nanopore with L64 provides the smaller pore size than the 
one with L121.  
 
3.3.3.2 Effect on Pore Size Distribution of Mesoporous Silica 
N2 adsorption-desorption isotherms were measured to assess pore size distribution 
and total surface area of the mesoporous silica thin films. The BJH pore size distributions 
for chips prepared by P123 (Fig.3.11.a), F127 (Fig.3.11.b), L64 (Fig.3.11.c) and L121 
(Fig.3.11.d) showed low pore size dispersion as denoted by the sharp distribution peaks 
and the adsorption/desorption isotherms (insets). Figure 3.11.a, b and c show Type IV 
adsorption/desorption isotherms with well-defined H2 hysteresis loops. The inflection 
points appearing at 0.40 ≤ P/P0 ≤ 0.75 indicate the formation of ink-bottle shape 
nanopores. The mesoporous silica thin films prepared using P123 and F127 possessed 
similar mean pore size (~3.7 nm) due to their identical PPO block volume, but the 
mesoporous silica prepared with P123 were characterized by a poor connectivity as 
indicated by the narrow hysteresis loop. Shown in Figure 3.11.d for chips prepared with 
L121, the pore diameter distribution peaks shift towards the right from 5.82nm to 6.79nm 
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and became broader with increasing amounts of the swelling agent. Their 
adsorption/desorption isotherms were also Type IV but with a H1 hysteresis loop which 
was attributed to the cylindrically shaped pores. Adding the certain amount of PPG did 
not result in any change in the loop shape, indicating that inner pore connectivity is not 
destroyed  by the swelling agent used for the chips prepared with L121. Although the 
mesoporous silica thin films prepared with L64 possesses  similar adsorption/desorption 
isotherms with L121, its shorter hydrophobic chain (PPO) led to nanopores with smaller 
pore size (~3.2 nm), as shown in Fig.3.11.c. 
 
Figure 3.11: Pore size distribution of nanoporous silica thin films prepared by different 
polymer as templates: a. P123; b. F127; c. L64; d. L121 and L121 with the 
molar ratio of 0.5 and 1.0 swelling agent (PPG). 
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3.3.3.3 Surface Hydropholicity of Mesoporous Silica Thin Films 
The hydrophilicity of chip surface was another factor to consider in selecting 
LMWP from serum. The contact angles of mesoporous silica thin film surfaces were 
tested by captive bubble contact angle goniometry to characterize the hydrophilicity of 
the chips’ surface. All mesoporous silica chips prepared with the four different tri-block 
copolymers were hydrophilic (contact angle < 30 °).  
 
Figure 3.12: Contact angle goniometry for mesoporous silica thin films. a. A 
representative image of contact angle measurements for the mesoporous 
silica chips prepared using L121; b. A chart of contact angles for all 
mesoporous silica thin film chips developed. 
 
Figure 3.12.a shows the image of a water droplet on the surface of a chip prepared 
with L121. This is a representative image illustrating the high hydrophilicity of the 
mesoporous silica thin film surface. The chart in Figure 3.12.b details the contact angles 
of all mesoporous silica thin film chips that have been developed. The mesoporous silica 
 74
thin films prepared from L121 exhibited the highest hydrophilicity due to the formation 
of their capillary condensation, increasing with the addition of the swelling agent.  The 
mesoporous silica thin film surface prepared by P123 presented the lowest hydrophilicity 
among all the chips examined in this study resulting in the highest contact angle.  
 
3.4 Conclusions 
Synthetic surfactant directed self-assembly allows for formation of different 
mesoporous silica thin film periodic nanostructures, which are formed using high 
molecular weight triblock copolymers such as Pluronic F127 with similar pore size 
distributions. The structural transformation can be obtained by tuning the polymer 
concentration in the precursor solution. With the change of interfacial curvature between 
the phases of polymer and solvents, nanostructure of final porous products can vary from 
periodic 2D-hexagonal, 3D cubic, to 3D honeycomb hexagonal. Precisely controlled 
variations in pore size can be achieved through the use of copolymers with differing 
hydrophobic block lengths to form pore sizes from 2nm to 10 nm. This range of pore 
sizes led to the recovery of a different repertoire of peptides and proteins from the same 
serum sample via size and shape exclusion. In the next chapter, we will discuss how the 
individual or integral use of different mesoporous silica thin films with carefully tailored 
characteristics provides a novel platform for the rapid and efficient analysis of the 




SERUM FRACTIONATION ON MESOPOROUS SILICA 
SUBSTRATES 
4.1 Introduction 
 A promising strategy for early disease diagnosis is the detection of molecular 
biomarkers from readily available body fluids, such as blood. [147, 152, 153] 
Considerable attention has been devoted to the development of proteomic methods for the 
quantitative and simultaneous detection and identification of molecular biomarkers, 
including various proteins and peptides, using Mass Spectrometry (MS). [35-37] prior to 
MS analysis, several sample treatment strategies have been developed including 
conventional 2-dimensional gel electrophoresis, pre-fractionation processes, depletion of 
most abundant proteins, and beads equalization.  In spite of these advances, less effort 
has been made to overcome the problems of sample denaturation and degradation during 
long sample handling procedures, maintenance of protein stability during sample 
processing, and stabilization of samples during long-term storage.  Furthermore, as we 
discussed in the previous chapters, the detection of low abundance and low molecular 
weight (LMW) species remains a critical challenge due to experimental variability, 
limited reproducibility, long sample handling procedures, protein stability during sample 
processing, and generation of misleading artifacts as a consequence of unreliable 
experimental procedures.  Innovative technologies addressing these issues are mandatory 
for discovery of new biomarkers. The development of nanomaterials, with controllable 
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features offering advantageous new physico-chemical properties, has widely improved 
the use of nanotechnology in biomedical applications. 
 In this chapter, we discuss the size-exclusion strategy for the exclusion of the high 
molecular weight proteins and for the specific isolation and enrichment of LMW species. 
This approach is based on combinatorial mesoporous silica substrate able to fractionate 
and selectively harvest peptides and proteins present in complex human biological fluids 
and protect them from enzymatic degradation. The mesoporous silica chips operate with 
rapidity, high reproducibility, no sample pre-processing, and substantial independence 
from sample acquisition and storage temperature. 
 
Figure 4.1: Principle of MSC fractionation and LMW enrichment. After sample spotting 
on the surface, LMW proteins and peptides are trapped into the pores while 
the larger species remained outside the pores and are removed during the 
washing steps. The enriched fractions are then eluted and analyzed by 
MALDI.  
 
Detailed protocol for serum fractionation using our MPS thin films will be 
described in the experimental section.  Briefly, the principle of this fast, on-chip 
fractionation strategy is shown in Figure 4.1: 1- The sample is spotted on the chip surface 
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and LMW molecules are trapped  in  the pores during the incubation step; 2- The larger 
protein species remain outside the pores and are removed during the washing steps; 3- 
The enriched small molecules are then eluted from the pores and further analyzed by MS. 
Matrix Assistant Laser Desorption/Ionization Time-of-Flight Mass Spectrometry 
(MALDI-TOF MS), a golden standard technology of today that is playing an essential 
role in proteomic study, will be briefly introduced before demonstrating the procedure of 
serum fractionation. To optimize the fractionation efficacy, several experimental 
parameters have been comprehensively investigated, such as temperature, sample 
amount, washing times, incubation duration, area of contact surface and selection of 
elution solvent. Due to the relative instability of blood samples, several publications have 
reported the importance of pre-analytical sample management to avoid the accumulation 
of artifacts and significant alterations in the proteomic profiles. [21] Therefore, 
fractionation reproducibility and reliability are mandatory for any further development of 
reliable proteomic and peptidomic screening techniques for clinical applications.  [154, 
155] To assess the consistency of our on-chip fractionation strategy, we screened 
multiple replicates with the same human serum sample using all of the mesoporous silica 
thin films we prepared. Finally, sample stability, the protection from degradation with 






4.2 MALDI-TOF MS in Proteomics   
4.2.1 Basic Principle 
Mass spectrometry (MS), an analytical technique used to determine the elemental 
composition of a molecule or peptide, has been used as a diagnostic tool or disease 
biomarker discovery platform in clinical laboratories for many decades. [18, 21, 31, 156-
161] The steps involved in MS are as follows: 1. ionizing chemical compounds to 
generate charged molecules or molecule fragments, 2. directing the ions into an electric 
and/or magnetic field, 3. measuring the m/z of the particles based on the details of motion 
of the ions as they transit through electromagnetic fields.  In 1980s, the development of 
the two ionization MS methods, electrospray ionization (ESI) and matrix-assisted laser 
desorption/ionization (MALDI), revolutionized protein chemistry and fundamentally 
changed protein analysis.   Coupled with gas chromatography, MS has been successfully 
used to identify and quantify relatively small molecules (with molecular mass <1,000 
Da). Although ESI gained immediate popularity because of its easy operation which 
combined popular chromatographic and electrophoretic separation techniques, MALDI 
integrated with a time-of-flight (TOF) mass analyzer is more suited to sensitive 
identification of a large range of peptides and proteins in complex samples. 
 
4.2.2 MALDI-TOF MS in Analysis of Peptides, Proteins and proteomics 
MALDI-TOF MS provides a rapid approach to identify the heterogeneity of 
peptides and proteins by determining their unique molecular mass. [162-165] When laser 
pulses are used to achieve desorption/ionization of proteins, molecular ions are formed, 
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most of whom are ionized to a single positive charge. But the occurrence of multiple 
ionic forms complicates the overall pattern and depends on variables such as sample 
composition, sample preparation, and type of matrix used. 
The restraints of MALDI-TOF MS depend on many factors that may change 
detection sensitivity by orders of magnitude, such as the ionization efficiency of different 
peptides, so any general statements about detection limits must be considered as rough 
approximations.  For small peptides, the detection limits of MALDI-TOF MS can extend 
to 1 mol under optimal conditions. Usually, larger peptides and proteins are detected with 
lower sensitivity and require concentrations > 1 µmol/L for analysis. This is particularly 
true for complex mixtures of proteins such as human serum, where 22 large proteins 
constitute ~99% of protein content and protein concentration possesses an extremely high 
dynamic range. Therefore, most plasma proteins detected by MALDI-TOF MS have 
concentrations >1 µmol/L without the extensive sample fractionation. 
In order to identify a specific peptide or protein by MALDI-TOF MS, the major 
challenge for many analyses of physiological fluids is to optimize the sample preparation 
which allows for the depletion of salts and enrichment of the protein or peptide of 
interest. Conventional methods for sample fractionation include chromatography, solid-
phase extractions, dilution, and fractionation directly on specialized target surfaces in 
SELDI-TOF MS or separation with magnetic particles. [166-174] However, these 
approaches often exhibit some drawbacks such as low efficiency, low-throughput and 
they are often not suited  to harvest the low molecular weight proteome, which 
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ultimately limits their potential to assist MALDI-TOF MS to be a key technology in 
clinical diagnostics.  
4.2.3 Mass Spectrometry as a Biomarker Discovery and Diagnostic Tool 
In 2006 the application of mass spectrometry as a diagnostic tool was first 
investigated by Petricoin and colleagues. [9] The MS profile in their study represented a 
paradigm shift in MS spectra between proteomic patterns in serum samples between 
patients with or without cancer identified by bioinformatics. It was realized that the 
potential to discriminate between different stages of disease should be further explored. 
As we discussed in origin of biomarkers, protein or protein fragments produced by a 
cell’s mutation or produced in a tumors’ microenvironment may eventually enter the 
general circulation. As a result, the change in concentration of these proteins/fragments 
could be analyzed by mass spectrometry and used for diagnostic purposes, in combination 
with biostatistics analysis. Studying the use of SELDI-TOF MS technology in the early 
diagnostics of ovarian cancer and prostate cancer has shown that the distinguishing peaks 
between cancer and non-cancer patients are very different between the various groups. 
However the disadvantages of this technique, including poor reproducibility and limited 
range of protein recovery, should be further considered.  
4.2.4 MALDI-TOF MS with Proteomic Nanochips 
In our study, the proteomic nanochips we developed were designed to overcome 
the drawbacks of conventional approaches used to detect serum biomarkers. This novel 
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nanotechnology-based method is showing the potential to extend the range of recovering 
proteomic biomarkers from human serum sample, particularly for those with low 
molecular weight, and improve the reproducibility of MS profiles for rigorous clinical 
request. The use of MALDI-TOF MS in this study plays a key role to providing the 
sensitive detection of LMWP. The serum fractionation on the proteomic nanochips has 
been discussed in the previous chapter. The details of operation on the extracted sample 
with MALDI-TOF MS are described as following. 
4.3 Experimental 
Serum Fractionation For each experiment, 10 μl of serum sample was pipetted 
onto the porous surface of the wafer square.  The samples were incubated for 30 minutes 
at 25 degrees (room temperature) in a wet chamber (100% humidity) to prevent sample 
evaporation. The samples were washed 5 times with 15 μl of sterile, deionized water. 
Peptides and proteins were eluted from the pores using a 1:1 (v/v) mixture of acetonitrile 
and 0.1 % trifluoroacetic acid (TFA) (Sigma).  
Mass Spectrometry   A matrix solution of 5 mg/ml α-cyano-4-hydroxycinnamic 
acid (CHCA, Sigma) in a 1:1 mixture of acetonitrile and 0.1% TFA(v/v) or a saturated 
solution of trans-3,5-dimethoxy-4-hydroxycinnamic acid (SA, Sigma) in 2:1 mixture of 
acetonitrile and water (v/v) containing 0.1 % TFA was used for LMW and HMW 
analysis respectively. Each of the samples was mixed with the appropriate matrix in a 
ratio of 1:3, and spotted in duplicate onto the MALDI plate.      
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        Mass spectra were acquired on a Voyager-DETM-STR MALDI-TOF (Applied 
Biosystems, Framingham, MA) mass spectrometer in liner positive-ion mode, using a 
337nm nitrogen laser. Samples were evaluated at two m/z ranges. For LMW peptides and 
proteins, m/z of 800-10,000 Da, using α-CHCA as matrix.  Settings were optimized at an 
acceleration voltage 20 KV, grid voltage 19KV, guide wire voltage 1KV, delay time 180 
ns, and low-mass gate 800. 300 laser shots crossed spot were averaged for each mass 
spectrum. For HMW proteins, parallel analysis using SA (Sinapinic Acid) as matrix and 
detection range of 3,000-100,000 Da was performed. The instrument was optimized at 
acceleration voltage 25 KV, grid voltage of 23.25 KV, guide wire voltage 6.25KV, delay 
time of 500 ns and low mass gate 3,000. 
        The spectra were calibrated externally using the ProteoMass standards of 
peptides and proteins (Sigma) in each mass range.  
         Statistical Analysis The raw spectra were processed with the Voyager Data 
Explorer software version 4.0 (Applied Biosystems) and the data was exported to 
SpecAlign software for pretreatment. [175, 176]  All spectra were aligned using the 
PAFFT correlation method and intensities were normalized to total ion current (TIC).  
The peak detection was performed with a height ratio of 2 with 0.3% of the mass 





4.4 Results and Discussion 
4.4.1 Serum Fractionation on Mesoporous Silica Thin Films 
Figure 4.2.a and b show the MS spectra of a serum sample with peptides in the 
range of 900 to 10,000 Da and proteins in the range of (3,000 ~ 70,000 Da); these serum 
samples have not undergone fractionation by the MPS thin films. These spectra illustrate 
the signal suppression in the LMW region due to the presence of well ionized, highly 
abundant, high molecular weight (HMW) proteins (Albumin, ApoA1). Figure 4.2.c and d 
depict the MALDI-TOF spectra of the serum sample after fractionation by the MPS thin 
films synthesized using L121 and swelling agent PPG at a molar ratio of 1:0.5. 
Enrichment of the LWM components is clearly evident as the majority of the large 
molecules in the serum sample haven been removed. As a control, the same serum 
sample was applied onto a nonporous pure silica surface to evaluate the specificity of 
MPS thin films for LMWP recovery. As can be seen in Figure 4.2e and f, there was not 
significant harvesting of peptides or proteins from the nonporous silica surface observed 
in the range of interest for both the peptide and protein mass. Thus it can be concluded 
that it was the mesoporous architecture and not the silica surface affinity that plays the 














Figure 4.2: Efficacy of serum fractionation using the mesoporous silica thin film chips. 
MALDI MS profiles in both the low mass range (900 to 10,000 Da) and the 
high mass range (3,000 to 70,000 Da) before (a, b) and after (c, d) 
fractionation using the mesoporous silica thin films. The molecular recovery 
is significantly reduced when using blank non-porous silica surfaces for 
fractionation (e, f). 
 
The substantial enrichment of LMW species is illustrated in Figure 4.3.a by 
comparing the MALDI intensities of common peptides and proteins before and after the 
on-chip fractionation. The efficient removal of the most abundant HMW proteins 
(Albumin, Apolipoprotein AI and Hemoglobin) is shown in Figure 4.3.b by comparing 




















Figure 4.3: a, the comparison of the peptide/Albumin ratio illustrates the enrichment of 
LMW peptides detected in both serum (in red) and elution (in black). b, 
Comparison of the intensities of Albumin, Apolipoprotein A1, and 






4.4.2 Reproducibility of Serum Fractionation on Mesoporous Silica Thin Films 
We screened 6 replicates with 6 aliquots of the same human serum sample using 
MPS thin films prepared by L121+PPG with a molar ratio of 1:0.5. Figure 4.4.a and b 
display the MALDI profiles in the mass range 900 to 10000 Da (peptide range) and 3,000 
to 70,000 Da (protein range) of 6 independently processed replicates of fractionated 
serum. They exhibit a highly reproducible peak identity and intensity. The general 
variability of the peak signals is illustrated on the histogram displaying the repartition of 
the coefficients of variation (CV) measured for each detected peak (Fig.4.4.c). The 
average CV was estimated at 13.1%, which demonstrated a high reproducibility for the 
detected peaks over a wide mass range of 800 to 20,000Da. The regression curve and 
equation comparing the peak intensities recovered from the replicates are illustrated in 
Figure 4.4.d and exhibit a coefficient of regression R²= 0.988. These results confirmed 
that the on-chip serum fractionation did not induce any significant variability in the 
sample and demonstrated the reliability of our MPS chips in the pre-treatment of complex 
biological samples. The minor statistical variations are due to the internal variability of 
the MALDI instrument. 
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Figure 4.4: Statistic study of reproducibility of on-chip fractionation on MS profiles of a. 
low mass range and b. high mass range, c. Average CV from histogram and 
d. regression curve. 
4.4.3 Evaluation of Protein Recovery 
In order to determine the sensitivity of protein recovery from the nanoporous 
chips, absorbance values were converted into protein amounts using the formula 
calculated through a standardization curve in Figure 4.5. For every experiment 
performed, results were internally standardized using known amounts of Albumin 
(0.5µg/ml to 30µg/ml) based on the instructions of the microBCA kit. 
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Figure 4.5: Standardization curve. A representative standardization curve made 
according with the instructions provided by the microBCA protein assay 
kit.  The graph shows the regression curve that fits the experimental 
results, its formula and its coefficient of determination (R2). The equation 
was used to convert the experimental data obtained through 
Spectrophotometer readings of sample absorbance at 562nm to the 
corresponding protein amount in µg. 
4.5 Optimization of Serum Fractionation on Mesoporous Silica Chips 
4.5.1 Effect of Contact Surface Area on Protein Fractionation 
To optimize the fractionation efficiency, three different masking strategies were 
developed and assembled on the mesoporous silica chips, defininga circular spotting area 
(diameter 10, 6.5, 3.25, 2 mm, as shown in Figure 4.5). For each mask type, we studied 
 89
the protein binding properties and assayed serum confinement and stability in the spotting 
area.  
The chips were patterned with a hydrophobic photoresist, SU-8 using 
photolithography. The SU-8 worked as a hydrophobic ring to confine the sample within 
the non-covered area. To define the SU-8 pattern, SU-8 was spin-coated on the 
nanoporous silica chip at 500 rpm for 20 seconds. Then the chip was baked on a hotplate 
(65°C 5 min, followed by 165°C 10 min). A pattern array of well defined shape and size 
was transferred to the silica film by contact photolithography. The resist was developed 
in SU-8 developer for 20 min, and the patterned wafer was post-baked at 95°C for 12 
minutes. Fabrication of patterned PDMS film was started by mixing elastomeric base and 
curing gel at a weight ratio of 10:1 followed by bubble removal in vacuum. 10g of PDMS 
was slowly poured into the mold, and allowed to settle. The mold was transferred to an 
hotplate (145 C, 20 min). The PDMS film was gently peeled off the mold and delivered. 
Silicone rubber masks were manufactured using 1.6mm thick silicone rubber sheets 
(transparent, 40 DURO hardness, with adhesive layer from 3M) obtained from 





Figure 4.6: Photographs of mesoporous silica chips patterned either with a 50µm thick 
SU-8 hydrophobic photoresist (a, c, e) or with a 500µm thick molded PDMS 
film (b, d, f). In C and D, note the relative thickness of the different material 
masks (SU-8 and PDMS respectively). The top views of different SU-8 and 
PDMS patterned chips (E and F respectively) with decreasing fractionation 
areas show the uniformity of the surfaces employed for the sample 
fractionation. g. Protein recovery from 12 independent experiments 
performed with increasing amount of serum samples (5, 10, 20 and 50 µl) on 
different nanoporous surface areas (diameters equal to 3.25, 6.5 and 10mm; 
same chip type) using the same settings (temperature, time, washings). 
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4.5.2 Effect of Sample Amount on Protein Fractionation 
To minimize the amount of serum needed, we studied the effect of sample volume 
on protein recovery on the different spotting areas. Depending on the profile of Figure 4.7 
we demonstrated that 10µl was the optimal sample size. 
 
Figure 4.7: Effect of sample volume on protein fractionation. a, Evaluation of the protein 
recovery from a series of fractionation experiments performed using different 
amount of serum on the same chip type. The amount of protein recovered is 
very low when only 1 and 5 µl of serum are used. Protein recovery reaches a 
plateau when 10 µl of serum are used. The incubation of 20 and 50 µl of 
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serum did not result in a higher protein recovery. b, The amount of protein in 
the washing samples increased with the increase of the serum used for 
fractionation.  
4.5.3 Effect of Washing Steps on Protein Fractionation 
The washing procedure was optimized to ensure complete removal of the HMW 
proteins absorbed on the surface of the MSCs. After each washing step, we performed 
MALDI analysis and measured the protein content. We determined that after 5 washes 
large proteins were almost absent, and that their peak intensity was negligible compared 
to the peak intensity of the LMW proteins and peptides (Fig. 4.8.a intermediate panels). 
The amount of protein removed during the washings decreased with each step and by the 
fourth wash, the amount of HMW proteins on the mesoporous silica chips surface was 
negligible compared to the amount of protein eluted from the chip. Figure 4.8.b exhibits 
that after 5 washes large proteins were almost absent. Moreover, the MALDI analysis of 
the samples eluted from the wafer did not show the presence of any Albumin or HMW 
protein confirming that the pores of the silica wafers could retain only LMW proteins and 
peptides. As displayed in Fig 4.8.c, the amount of protein recovered from the chip in the 
elution step was significantly higher than the amount of protein measured in the last 2 
washing steps. A possible explanation for this result is that by the fourth and fifth washes 
the amount of protein on the surface was almost null. Additional washing would remove 
the LMW proteins trapped into the nanopores of the mesoporous silica chips. On the 
basis of these considerations, we concluded that the minimal number of washing steps 
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required was 5 and performed all the experiments described in the paper accordingly. 
 
 
Figure 4.8: a. The MALDI profiles of the different steps of the methodology demonstrate 
the depletion of most abundant HMW proteins in the washings and 
enrichment of LMW species in the elution. b, Histogram comparing the 
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amount of protein removed during the washing steps. In the first wash, the 
amount of protein positively correlated with incubation time. Mean values and 
standard deviations of 3 independent experiments are shown. c, Comparison 
of protein recovery in the last 2 washing steps and in the final elution. In all 
conditions tested, the amount of eluted protein is significantly higher than the 
amount of protein removed from the surface during the last 2 washings. 
4.5.4 Effect of Temperature on Protein Fractionation 
To understand the effect of temperature on protein fractionation and identify the 
best working condition, experiments were performed at 4° C, 25° C and 37° C (Fig. 4.9). 
Protein recovery at 25° C and 37° C was not significantly different (Fig. 4.9.a), but 25° C 
was chosen as the optimal working temperature because of the associated higher 
reproducibility (Fig. 4.9.c and d). For all the chips tested, recovery was very low at 4° C.  
The low temperature might have affected process of diffusion into the nanopores [177] as 






















Figure 4.9: a, MALDI profiles of fractionated serum on X10 chip illustrate the increase of 
LMW peptides and proteins detection when the serum is processed at 25°C 
compared to 4°C and 37°C. b, c, d, Linear regression analysis of the average 
intensities of detected MS peak for each temperature. The comparison was 
plotted on a log–log scale to obtain a scatter-plot.  
4.5.5 Effect of Incubation Duration on Protein Fractionation 
By running the experiment at 25° C with fixed volumes of serum, we studied the 
influence of incubation time on protein recovery. 5, 15, 30 and 60 minutes of incubation 
time were carried out to investigate their effect to protein recovery. We concluded that 
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after 30 minutes of incubation, protein recovery reached a plateau, which is displayed in 
Figure 4.10. Further incubation time may increase protein degradation while not 
increasing protein recovery from the mesoporous silica chips. Figure 4.11.a exhibits 
MALDI profiles for protein recovery with four different incubation times. Statistical 










Figure 4.10: Effect of incubation time on protein fractionation. Total protein recovery 
after fractionation performed at different incubation times.  
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Figure 4.11: MALDI spectra obtained after different incubation times. a, MALDI profiles 
of fractionated serum on the mesoporous silica chip at different incubation 
time (5 min, 15 min, 30 min, and 60 min). The peak intensity is markedly 
lower for the 5 min incubation. The profiles for 15 min, 30 min, and 60 min 
show similar profiles. b, Linear regression analysis of the triplicate average 
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intensities of detected MS peak compared to replicate 1 for each incubation 
time. The comparison was plotted on a log–log scale to create a scatter-plot.  
 
4.6 Sample Stability, Protection from Degradation  
The use of MS profiling to correlate a disease with the specific changes in the 
circulating proteins is a promising tool to improve diagnosis, to allow the design of 
personalized therapies and to follow their efficacy in real time and with low invasiveness. 
Stability and reliability are crucial features for any clinical applications. To address the 
issue of protein stability we incubated the mesoporous silica chips with human serum, 
dried the chips after the washing steps, and stored them for 3 weeks. The same procedure 
was used to evaluate the stability of peptide and protein standards. Compared with a 
freshly fractionated sample, the results demonstrated similar peptide patterns as 
illustrated in Fig. 4.12.a and b. Based on  mechanisms similar to those postulated by 
Luchini et al. [179] for hydrogel particles, we hypothesize that the LMW species trapped 
inside the nanopores were preserved from degradation through the exclusion of proteases 
from the nanopores, or by steric inhibition of their proteolytic activity in the confined 
space of the nanopores. The establishment of a simple sample acquisition and storage 
protocol and the ability to impede further degradation of the proteins and peptides once 
they are captured are crucial properties for translation of this new technology into the 
laboratory clinical practice [180, 181]. With previous methodologies, differences in blood 
sample acquisition, time elapsed before contact of the serum onto the capture surfaces, 
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environmental temperature and storage temperatures all resulted in the degradation-
induced appearance of peaks that confounded the analyses and rendered meaningless the 
use of the profiles to derive any diagnostic or otherwise medically significant 
information. The fundamental advantage of the present approach, which makes it 
clinically viable, is that untreated blood can be drawn and directly placed onto the 
mesoporous silica chip, resulting in a pattern of stored information that is reproducible 
































Figure 4.12: a. Representative MALDI profiles of LMW peptides and proteins eluted 
immediately after serum fractionation or after 3 week on-chip storage at 
room temperature. b, c, d, Linear regression analysis of average intensities 
of detected MS peak in each replicate compared to replicate 1 for crude, 
fractionated serum and fractionated serum after 3 week storage at room 
temperature respectively (the coefficient of variation (CV) and the 




The fractionation device composed of mesoporous silica thin films displays 
features that are desirable for exploratory screening and biomarker discovery. The 
constituent mesoporous silica chips may be custom-tailored for the sequestration and 
enrichment of extremely low abundance protein and peptides in desired ranges of the 
mass/charge spectrum. They are effective and yield highly reproducible extracts from 
extremely complex biological samples. They can process samples as small as 10 µl in a 
time as short as 30 minutes. They are inexpensive to manufacture, and their production 
can be easily scaled up to attain the simultaneous processing of a large number of 
samples. They are multiplexed, label-free diagnostic tools with the potential for 
additional modification with biological recognition moieties, for enhanced specificity. 
The mesoporous silica chips may be used to store, protect, and stabilize protein and 
peptide extracted from biological fluids to enable the collection and transport of clinical 
samples with simplified and cost-effective procedures. In the next few chapters, we will 
continue to expand the methods by whichour mesoporous silica chip based device may 
serve as diagnostic tool to complement histopathology, imaging and other conventional 
clinical techniques. The mesoporous silica chip-mediated identification of entire disease-
specific protein networks may help in the selection of personalized therapeutic 
combinations, in the real-time assessment of therapeutic efficacy and toxicity, and in the 
rational modulation of therapy based on changes in the protein network associated with 




SELECTIVE RECOVERY OF LMWP ON MESOPOROUS SILICA 
CHIPS WITH VARIOUS NANOTEXTURES 
5.1 Introduction 
In Chapter 3, we demonstrated that mesoporous silica films produced by 
evaporation-induced-self-assembly (EISA) during spin-coating showed tunable pore size, 
pore connectivity and structure. Using a range of processing conditions, we performed an 
extensive and rigorous characterization of the mesoporous silica thin films fabricated. In 
this chapter, we will control the nanotexturing (pore size and pore structure) with 
synthetic chemistry in order to selectively enrich fractions of interest of the serum 
proteome in the low molecular weight range. It is widely accepted that when the 
mesopore diameter is large enough to facilitate the comfortable entrapment of 
biomolecules, analytes will penetrate deep into mesoporous networks rather than become 
adsorbed onto the external surface. [182] We speculated that mesopores would have the 
right dimensions for tunable peptide entrapment.  With the assistance of matrix-assisted 
laser desorption/ionization time-of-flight mass spectrometry (MALDI TOF MS) and 
statistical analysis, we demonstrated the correlation between the nanophase 
characteristics of the mesoporous silica thin film and the specificity and efficacy of low 
mass proteome harvesting. The tunable physico-chemical properties of mesoporous silica 
surfaces made this novel material a powerful tool in selectively separating and 
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concentrating the different low molecular weight subproteomes from complex biological 
fluids.  
Generally speaking, the study on the relationship between pore nanotexturing and 
LMWP harvested is the key to enhancing our ability to recognize disease-biomarkers 
with this nanotechnology. As we mentioned in previous chapters, the large range and 
sheer complexity of make the characterization of human serum a challenging task. [183] 
Although the low mass peptidome has been fractionated and enriched from human serum 
with our novel nanotechnology, the necessary categorization and specific recovery of  
this resource are still an essential prerequisite for high-throughput and large-scale clinical 
studies. 
Before testing with human blood, we mixed commercialized peptides and proteins 
with a broad range of molecular weights, sizes and structures to mimic the biological 
complex. All peptides and proteins were verified by MS for its identity and purity. Then 
the fractionation of the mixture was carried out on the mesoporous silica chips with 
different pore size distributions. MS profiles of the molecular weight standards in the 
peptide and protein range were analyzed respectively to avoid the interference of large 
proteins to identify peptides. The results presented in this paper reveal the potential of 
nanoporous chip based technology to provide a powerful alternative to conventional 
methods for LMWP harvesting from complex biological fluids.  
In the analysis of the fractionation and purification of LMW species from human 
serum, the mesoporous silica chips used in this study were split into two categories based 
upon the properties of the material: 1. pore size, 2. pore structure. According to their 
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harvesting characteristics, selective enrichment and specific recovery patterns, each of the 
MSCs identified unique proteomic signatures.  
 
5.2 Materials and Experimental 
5.2.1 Materials 
The materials used to fabricate the mesoporous silica thin films are the same as 
described in previous chapters. 26 standard peptides and proteins (proteoMass peptide 
and protein MALDI-MS calibration Kit, MSCAL1-1KT) were purchased from Sigma-
Aldrich Co.. 
5.2.2 Experimental Sections 
The molecular weight standards were combined, dispensed in equal amount, dried 
by vacuum centrifugation, and stored at -20oC. 10 µl of the standard solution was spotted 
onto the nanoporous surface of the mesoporous silica chip. The samples were incubated 
for 30 minutes in a wet chamber (100% humidity) to prevent sample evaporation.  The 
Chip surface was washed 5 times with 15µL of sterile, deionized water.  Proteins were 
eluted from the pores by using 10µl of a 1:1 mixture of acetonitrile and 0.1 % 
trifluoroacetic acid (TFA) (v/v).  
5.2.3 Mass Spectrometry 
A matrix solution of 5 mg/ml  α-cyano-4-hydroxycinnamic acid (αCHCA, 
Sigma) in a 1:1 mixture of acetonitrile and 0.1% TFA(v/v) and a saturated matrix 
solution of trans-3,5-dimethoxy-4-hydroxycinnamic acid (SA, Sigma) in 2:1 mixture of 
acetonitrile and 0.1 % TFA was used for LMW and HMW peptides and proteins 
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respectively. Each sample was mixed with the appropriate matrix solution in a 1:3 ratio, 
and spotted in duplicate onto the MALDI plate. Mass spectra were acquired on a 
Voyager-DETM-STR MALDI-TOF (Applied Biosystems, Framingham, MA) mass 
spectrometer in liner positive-ion mode, using   a 337nm nitrogen laser. Samples were 
evaluated at two m/z ranges. For the m/z range of 800-10,000 Da, settings were 
optimized at acceleration voltage 20 KV, grid voltage 19KV, guide wire voltage 1KV,  
delay time 180 ns, and low-mass gate 800. For the m/z range of of 3,000-100,000 Da, the 
instrument was optimized at acceleration voltage 25 KV, grid voltage of 23.25 KV, guide 
wire voltage 6.25KV, delay time of 500 ns  and low mass gate 3,000. Each spectrum was 
the average of 300 laser shots. The spectra were calibrated externally using the 
ProteoMass standards of peptides and proteins (Sigma) in each mass range.  
5.2.4 Data Processing and Statistics 
The raw spectra were processed with the Voyager Data Explorer software version 
4.0 (Applied Biosystems) and the data were exported to SpecAlign software for 
pretreatment.  [175, 176] All spectra were aligned using the PAFFT correlation method 
and normalized to total ion current intensity.  The Peak detection was performed with a 
height ratio of 2 with 0.3% of the mass window. The baseline was corrected and the 
negative values were removed prior to analysis. 
We used t-test (Student) to select differentially harvested peptides and proteins 
among the different nanoporous proteomic chips. Hierarchical clustering was performed 
using Cluster software and visualized with Treeview software [184]. 
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5.3 Standard Peptides and Proteins Mixture 
5.3.1 Effect of Pore Size on Fractionation 
Table 5.1: Summary of physico-chemical properties of the selected peptide and protein 
standards and variability of peak intensities for each LMW marker. The 
standards were combined, dispensed in equal amount, dried by vacuum 
centrifugation, and stored at -20oC. The stability of the set of standard was 
investigated by MS and no degradation was found. The coefficient of 
variations of the intensities of peaks after 2, 3, 5, and 8 days storage at -20oC 


















We selected 26 peptides and proteins (Table 5.1) with a broad range of molecular 
weights (900-66,500 Da), isoelectric points (pI 4.0-10.2), and structures and used them to 
standardize the chips, the sample preparation, the MS analysis and the data processing. 
Each peptide and protein was verified by MS for its identity and purity (see Figure 5.1).  
In order to assess size exclusion during the fractionation, we selected mesoporous 
silica chips with pore sizes ranging from 2.7 nm to 8.9 nm. Figure 5.2.a and b illustrate 
the MS profiles of the molecular weight standards in the peptide and protein range 
respectively. When the peptide standard mix (16 markers from 900 to 8500 Da) and the 
protein standard mix (16 markers from 3400 to 66500 Da) were resolved by MALDI, 
their spectra showed a high detection signal and clear identification of all the molecular 
species. The spectra in Figure 5.2.a include the MS profiles for 16 peptides mixture (top), 
the peptide fraction in 26 peptides and proteins mixture (middle) and the recovered 
peptides from fractionation on mesoporous silica chips (bottom). It clearly implies that 
when combined in a unique solution, the detection signal in the peptide range 
dramatically decreased while the larger proteins remained well detected (Fig. 5.2.a and 
b). The signal suppression in the LMW was due to the presence of large amount of well 
ionized HMW molecules such as Albumin and mimicked the limits of MS analysis of 
serum and plasma. After fractionation on the mesoporous silica chips, larger proteins 
were removed and the detection of the LMW species significantly increased. Figure 5.2.c 
shows a magnified view of the spectra illustrating the size-dependent removal of larger 
proteins and the experimental molecular cut-off observed for each chip. Figure 5.2.d 
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presents a two-way hierarchical clustering showing the positive correlation between pore 
size, molecular weight of the trapped species and enrichment of the LMW standards. 
Mesoporous silica chips with larger pores preferentially harvested bigger peptides (from 
3600 to 8500 Da), while smaller peptides (from 900 to 3500 Da) were recovered more 
efficiently by the chips with smaller pores. 
 
 
Figure 5.1: Stability of peptide and protein standards. Representative MALDI profile 
of the LMW (a) and HMW (b) standards respectively. The stability of the 
set of peptide (16 weight markers from 900 to 8,500 Da) and protein (16 
weight markers from 3,500 to 66,500 Da) in stock solution was 
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Figure 5.2: Evaluation of the molecular cut-off of the MSCs using a library of peptide 
and protein markers. a, b, Detection of the molecular weight standards by 
MALDI-TOF in the peptide (800 to 10000 Da) and in the protein range (3000 
to 100000 Da). For the separated mixes of peptides (16 markers from 900 to 

























































present a high level of detection for each species. In the combined mix, the 
signal suppression of LMW standards is due to the high concentration of 
HMW proteins. In the MALDI profiles of the combined standard mix after 
fractionation on the MSC with 7.36 nm pore size, the detection of LMW 
markers is significantly increased compared to the unprocessed sample. c, 
Magnified view of the MALDI spectra demonstrating the characteristic 
molecular cut-off of each MSCs correlates to the pore size. d, Two-way 
hierarchical clustering of the peptide mix features among the different chips. 
The intensity of the red or yellow color indicates the relative peptide 
concentration. Larger pores enhanced the harvesting of bigger peptides (from 
3600 to 8500 Da), while the small peptides (from 900 to 3500 Da) were 
preferentially recovered from the chips with smaller pores.  
 
5.3.2 Effect of Pore Structure on Fractionation 
As we demonstrated in Chapter 3, it was possible to fabricate MPS thin films with 
different pore morphology. Herein the effect of the structural variation of the mesoporous 
F127 nanochips (3D cubic, honeycomb hexagonal and 2D hexagonal) on the specific 
enrichment of LMW species was investigated. As shown in Figure 5.3, mesoporous silica 
thin films with similar pore size distributions, around 3.7 to 3.9 nm, and the three 
different nanostructures (Figures 5.3.a for 3D cubic, Figures 5.3.b for 3D honeycomb-like 
hexagonal and Figures 5.3.c for 2D hexagonal) exhibit the same molecular cut-off for 
peptide and protein recovery from serum fractionation. For both 3D nanoporous 
morphologies, the increased pore connectivity and the reduced steric hindrance imposed 
on the diffusion of peptides and proteins resulted in higher recovery efficacy. The 
dramatic difference in the MS profiles for peptides recovery in the range of 800 ~ 
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10,000Da between 3D nanostructures and 2D hexagonal framework was shown in Figure 
5.4.a, b and c. The average coefficient of variation (CV) determined from the histograms, 
for 3D cubic structure (Fig.5.4.d) or 3D honeycomb hexagonal structure (Fig.5.4.e) is 
considerably lower than that of the 2D hexagonal architecture (Fig.5.4.f), which shows a 
broader CV distribution. These results indicate that the serum fractionation on the MPS 
thin film with a 3D nanotexture possesses a comparatively lower variability because of 












Figure 5.3: Molecular cut-off for F127 chips. The Molecular cut-off of recovered proteins 
shown for the MPS thin films prepared by Pluronic F127 with different 
nanoscale morphologies: 3D cubic (a), 3D honeycomb hexagonal (b) and 2D 























Figure 5.4: Effect of pore structural transformation on LMWP recovery from F127 chips. 
The MALDI profiles for the 3D cubic (a), 3D honeycomb hexagonal (b) and 
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2D hexagonal (c) nanoscale morphologies, respectively. The coefficients of 
variation (CV) distributions of MS peak intensities for each of the MALDI 
profiles are also shown (d, e, f). The average CV and the number of detected 
peaks are indicated in each histogram. 
 
For some specific peptides or proteins, the 2D hexagonal and 3D nanostructures 
display differential peptide enrichment. As shown in figure 5.5, there is a significant 
increase of the capture of ACTH and Insulin peptides on the hexagonal surface while 
Substance P and a-Endorphin peptides are specifically recovered from the mesoporous 
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Figure 5.5: Intensity Bar graph of specific peptides recovery on 3D-Cubic and 3D-
Hexagonal F127 mesoporous silica chips. The different structural 
modifications present a selective enrichment.  
 
5.4 Selective Recovery of LMW Peptides and Proteins from Human 
Serum 
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The different LMW peptide and protein enrichment spectra are illustrated in 
Figure 5.6.a for the mesoporous silica chips prepared with L64, F127, L121+50%PPG 
and L121+100%PPG. Though it possessed a similar pore size to the MPS thin film 
prepared from F127, the relatively higher hydrophobicity, smaller pore volume, and poor 
pore connectivity of the mesoporous silica thin film fabricated with polymer P123 
presented limited harvesting capability, as shown in Figure 5.6.b. With the largest 
average pore size and the highest surface hydrophilicity, the mesoporous silica chip 
produced using L121+PPG captured peptides and proteins in a wider molecular mass 
range. The chips with small pore size were prepared with F127 and L64 and 
preferentially enriched the peptides in the lower mass range. To assess this size-
dependant ability of the mesoporous silica chips to capture LMWP, a hierarchical 
clustering analysis of peptides extracted from four different mesoporous silica chips with 
various pore sizes was performed (Fig.5.6.c). The clustering algorithm clearly separates 
the samples into two major clusters representing specific proteomic patterns for smallest 
pore and largest pore chips. The high intensity of smaller LMWP was obtained with the 
chips prepared with L64 and F127 due to their preferred pore sizes, 3.20nm and 3.71nm 
respectively. However, the periodic pore structure and uniform small pore size provided 
by F127 chips demonstrate a more homogeneous enrichment pattern. The mesoporous 
silica chips prepared by L121, with the pore sizes enlarged using the swelling agent 
(molar ratios of 50% to 100% PPG to template polymer,) offer increased selective 
capture of peptides and proteins with higher molecular weight. The larger pore size 
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presented by the L121 with 100% PPG resulted in more efficient recovery as illustrated 















Figure 5.6: Effect of pore size on LMWP recovery. a. Mass spectra of the proteins and 
peptides collected from samples  fractionated using chips prepared with 
L64, F127, L121+50%PPG and L121+100%PPG (top to bottom), b. MS 
profiles of the samples fractionated using chips prepared with P123, c. The 
supervised hierarchical clustering analysis of peak intensities for samples 
fractionated using chips prepared with F127, L64, L121+50%PPG and 
L121+100%PPG. Red indicates peak intensities higher than the median 
value, green is for peak intensities lower than the median value, and black 
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represents peak intensities equal to the median value. Each row represents an 
individual mass peak (MALDI MS peak) and each column represents a 
mesoporous thin film chip produced using a specific triblock copolymer.  
 
5.5 Conclusion 
In conclusion, the fractionation device presented here displays features that are 
desirable for exploratory screening and biomarker discovery. The constituent mesoporous 
silica chips may be custom-tailored for desired pore sizes and surface properties as 
needed for the sequestration and enrichment of extremely low abundance protein and 
peptides in desired ranges of the mass/charge spectrum. They are effective and yield 
highly reproducible extracts from extremely complex biological samples. After being 
optimized, they can process samples as small as 10 µl in a time as short as 30 minutes, as 
described in Chapter 4. They are inexpensive to manufacture, and their production can be 
easily scaled up to attain the simultaneous processing of a large number of samples. They 
are multiplexed, label-free diagnostic tools with the potential for additional modification 









TREATMENT ON THE SURFACE OF MESOPOROUS SILICA 
CHIPS AND ITS EFFECT ON SELECTIVE RECOVERY OF LMWP 
 
6.1 Introduction 
The selective isolation and enrichment of low molecular weight peptides and 
proteins from human serum are of considerable interest. As we discussed in previous 
chapters, due to the extremely high dynamic range of protein concentration and the 
interference of large proteins (i.e. albumin), specific recovery of LMW proteome is a 
considerable challenge. In Chapter 5, we demonstrated the efficacy of mesoporous silica 
chip in harvesting LMW peptides and proteins from biological complex (i.e. human 
serum). In this study, surface affinity for water is tuned by applying high power oxygen 
plasma (to induce hydrophilicity) or coating gas-phase hexamethyldisilazane (HMDS, to 
induce hydrophobicity). In addition, several common organic functional groups were 
conjugated on the surface of mesoporous silica thin film to enhance the selectivity of 
recovering low mass peptides.  
Organic-inorganic hybrid materials prepared by the sol-gel approach have 
attracted a great deal of attention in materials science. Sol–gel, a highly adaptable 
process, allows for homogeneous mixing of inorganic and organic components at a 
nanoscale, leading to the so-called hybrid organic–inorganic nanocomposites. [78, 185-
188]    Through the covalent coupling of organic or organo-metallic moieties, chemical 
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functionalization of the inorganic framework of porous materials has been recognized as 
a promising approach to tailor pore surface properties such as charge, polarity, optical 
activity, and electronic activity. [135, 189, 190] The synthesis of hybrid mesoporous 
silica materials could open up new avenues for organometallic chemistry, catalysis, and 
organic-inorganic host-guest chemistry. There are two main approaches for organo-
functionalization of ordered mesoporous silica-based solids: post-synthetic methods [137, 




Figure 6.1: Pre-functionalization (A) and post-functionalization (B) routes towards hybrid 
materials organized in the mesoscopic scale. The meso-organized precursors 
are synthesized by reacting an inorganic precursor in the presence of a 
supramolecular template (surfactant). By route A, organic functions can also 
be embedded within the walls. Adapted from reference [199]. 
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Post-grafting is a straight-forward method to add organic groups, such as 
RxSi(OR )3–x or RxSiCl4–x, onto the surface of the pores. This approach has been widely 
employed to conjugate various organic groups onto the surface of the pores, including 
organometallic species, amino and thiol group, and epoxide group. However, post-
grafting often leads to a quite low loading content and an inhomogeneous distribution of 
the functional groups. [190] Therefore, more research groups focus their attention on one-
spot synthesis. This technology involves co-condensation of tetraalkoxysilanes and 
organotrialkoxysilanes in the presence of surfactants during synthesis, resulting in higher 
organic content and a more homogeneous organic distribution in the material.  
Functional groups, such as vinyl, phenyl, aminopropyl, cyanoethyl and 
diphenylphosphanylpropyl, have been incorporated into the inorganic network by this 
method. However, co-condensation in one-spot synthesis also caused several difficulties 
in addition to the control of the main parameters related to the EISA process. For 
instance, homogeneous solubility of the organic functionalities with silicate precursor in 
the medium limits the selection of surface modification. When the silylated probe is 
poorly soluble or insoluble in the alcoholic solvent, segregation or aggregation may take 
place. In the other hand, because of the consideration about the calcination step, 
surfactant templates have to be chose in a small range, where the polymers should own 
the distinguished melting point with that of organotrialkoxysilanes. Another influencing 
factor is the choice of co-solvents. One-spot synthesis requires the co-solvent not only to 
dissolve the desired organo-functional molecules but also to be miscible with the silicate 
precursor. In the case of mesoporous silica thin film preparation, the co-solvent must be 
 122
evaporable and must possess good wettability towards chip substrates. Lastly, the 
participation of organosilane into nanostructured films may lead to the significant 
damage in the silica network.  
We improved the method of conjugating various organosilane compounds on the 
mesoporous silica chips. Herein, based on post-grafting approach, plasma ashing was 
used for the first time for the treatment of the mesoporous silica surface prior to chemical 
modification. The results show the improvement of functional group loading and the 
compatibility of this method for all synthetic templates and organosilanes. Opposite 
surface charges, due to the different functional groups used, resulted in distinctive 
selectivity of the low molecular weight proteins from the serum sample. 
 
6.2 Materials and Experimental 
6.2.1 Materials 
The materials used to fabricate the mesoporous silica thin films are the same as 
those described in previous chapters. All organosilanes were purchased from Sigma-
Aldrich Co., including Aminopropyltrimethoxysilane (APTES), 
Mercaptopropyltrimethoxysilane (MPTES), Cyanoalkyltriethoxysilane and 3-
Chloropropyltriethoxysilane. Their chemical formula is displayed in Figure 6.2.  
 
 


















                                                                                              
 
                     Hexamethyldisiazane 
 
Figure 6.2: Chemical formula of organosilanes 
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6.2.2 Experimental Sections 
6.2.2.1 Control on Surface Hydrophilicity 
Oxygen plasma treatment was performed in a Plasma Asher (March Plasma 
System) to ensure hydrophilicity. The treatment was carried out in a Plasma Asher 
(March Plasma System) with an O2 flow rate at 80 sccm and a power of 300 W for 10 
minutes. Coating of Hexamethyldisilazane (HMDS) was performed in a HMDS vapor 
prime oven (YES) at 150oC for 5 min, in order to make the surface hydrophobic. Contact 
angles of MSC surface were measured by a goniometer with captive bubble contact angle 
measurement to evaluate the hydrophilicity of the films.  
6.2.2.2 Conjugation of Organic Functional Groups on Chip Surface 
The Mesoporous silica chips were treated by plasma ashing before silanization. 
Then silanate chips in a 3% organosilane in a Methanol:DI water (19:1) solution for 72 
hours at room temperature in N2 glovebox. Rinse sequentially with Methanol and DI 
water. Finally chips were cured at 110°C for 15 min in a fan-operated oven.  
 
6.2.3 Characterization 
Several characterization techniques are used in the section of surface 
modification, including ellipsometry, XRD, contact angle, TEM and N2 
adsorption/desorption. The description about these techniques has been listed in Chapter 
3. XPS was extensively used in this study to investigate the loading density of 
organosilane on the mesoporous silica chips. 
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6.2.4 Sample Fractionation  
 Same description as Chapter 5. 
6.2.5 Mass Spectrometry 
Same description as Chapter 5. 
6.2.6 Data Processing and Statistics 
Same description as Chapter 5. 
 
6.3 Results and Discussion 
6.3.1 Surface Treatment 
6.3.1.1 Oxygen Plasma 
Plasma ashing is a well-known technique for removing the photoresist in 
semiconductor manufacturing. Using a plasma source, a monatomic reactive species is 
generated. Oxygen is the most common reactive species. Photoresist combines with the 
reactive oxygen to form ash and can be removed under a vacuum condition.  
Although it experiences recombination during the channeling, monatomic oxygen 
is electrically neutral. The positively or negatively charged free radicals attract one 
another at a higher rate. Effectively, this means that when all of the free radicals have 
recombined, there is still a portion of the active species available for process. The 
objective to use oxygen plasma in our study to modify the defect on mesoporous silica 
thin film caused during their formation under high temperature. Calcination temperatures 
higher than 350 °C are often employed for this purpose. This process causes loss of 
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surface hydroxyl groups due to extensive dehydration. It is supposed that the reason for 
damage to the intermediate silica film in this case is that Si--R group (R refers to lower 
alkyl group or hydrogen atom) is decomposed (R group is separated) by the ashing 
process and a Si--OH bond is produced. The surface with Si-OH bond has been proved to 
be more hydrophilic than that with Si-H.  
Table 6.1 listed the ellipsometry results before and after oxygen plasma treatment 
for mesoporous silica thin films respectively prepared by three surfactant templates: 
CTAB, F127, and L121 with 50% of PPG. Either thickness or porosity for the chips 
with/without oxygen plasma doesn’t exhibit the significant difference, which illustrates 
that the surface treatment does not affect the configuration of silica thin film and pore 
dimension. However, the change of surface contact angle (Fig.6.3) indicates that the 
hydrophilicity of mesoporous silica thin film has been improved after being treated with 
oxygen plasma. Figure 6.3.a, c and e show the surface contact angles for the chips 
prepared with CTAB, F127 and L121+50%PPG. The water drop in the image has 
displayed their hydrophilic property (CTAB chip: 18.13°, F127 chip: 12.48°, L121+PPG 
chip: 7.83°). After the treatment of oxygen plasma, their surfaces become much more 
hydrophilic (CTAB chip: 6.73°, F127 chip: 7.50°, L121+PPG Chip: 3.76°). Clearly, the 




Table 6.1: Ellipsometry results for mesoporous silica chips prepared by CTAB, F127 and 
L121+50%PPG, with different surface treatment, oxygen plasma or HMDS 
coating. 
Samples Average Thickness (nm) Average Porosity (%) 
CTAB 530.23 44.348 
CTAB w/ oxygen plasma 534.83 46.823 
CTAB w/ HMDS coating 542.59 32.262 
F127 548.86 43.347 
F127 w/ oxygen plasma 548.26 43.854 
F127 w/ HMDS coating 547.83 32.500 
L121 +50%PPG 575.69 62.085 
L121 +50% PPG w/ oxygen 
plasma 
574.11 62.476 



















Figure 6.3: Contact angle images for the mesoporous silica chips prepared with a. CTAB 
b. CTAB with oxygen plasma, c. F127, d. F127 with oxygen plasma, e. 






6.3.1.2 HMDS Coating 
In contrast, we improve the hydrophobicity of mesoporous silica films by treating 
them with HMDS (hexamethyldisilazane) vapor at 160 °C. The resulting pore surface is 
occupied by hydrophilic silanol groups, and can be further modified through HMDS 
silyation to become hydrophobic. [200, 201] With a reaction: 
2≡Si–OH + (Me)3Si–NH–Si(Me)3 → 2≡Si–O–Si(Me)3 + NH3 
 
HMDS coating is also a popular technique in semiconductor industry. A 
commonly known problem in photolithography on siliconoxide (SiO2 or glass) and 
silicon (Si) surfaces is poor adhesion of the photoresist. Therefore, an adhesion promoter 
is applied. Compared to other adhesion promoter HMDS not only reacts with water but 
also with silanol groups at the SiO2 or Si surface, respectively. For maximum adhesion of 
photoresist, the wafer surface must be completely free of moisture. The quality of the 
photoresist adhesion sets the stage for all that follows. Vapor Priming allows the 
application of HMDS in a monolayer. Contamination issues are reduced by exposing the 
wafers to HMDS vapor rather than liquid. The reduction of liquid required for a vapor 
deposition lower the cost compared to the liquid application of spin priming. 
With the coating of a HMDS layer, the thickness of mesoporous silica layer is 
increased but the porosity is reduced, as listed in Table 1. Meanwhile, their surfaces 






Figure 6.4: Contact angle images for the mesoporous silica chips prepared with a. CTAB 
with HMDS coating, b. F127 with HMDS coating, c. L121+50%PPG with 
HMDS coating. 
6.3.1.3 Selective Recovery on the Chip Surface with Various Hydrophilicities 
In order to improve the fractionation and purification of LMW species from 





hydrophobicity. To further illustrate the specific recovery pattern of our nanoporous 
surfaces, we performed supervised hierarchical clustering (Figure 6.5). An independent 
Student t-test was used for comparison between groups (n = 2 groups) for each detected 
MS peak. A P value of 0.02 or lower was considered significant to select differentially 
harvested peptides and proteins among the different nanoporous proteomic chips 
(Hydrophobic vs. Hydrophilic). These results show the selective enrichment pattern 
obtained after serum fractionation on proteomic nanochips with different surface 
hydrophilicity.  
             








Figure 6.5: Effect of surface hydrophilicity on serum peptide harvesting. Supervised 
hierarchical clustering and specific recovery pattern for each set of 
nanochips as indicated in the figure. The relative intensity is gradually 
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indicated with red squares (high intensity), black squares (median) and 
green squares (low intensity or absence of a peak).  
 
 
Figure 6.6 are MS profiles for the chips made by the same polymer template, but 
with different surface treatment. It illustrates that the hydrophobic surface prefers to 
enrich peptides present in the very low molecular weight region, while hydrophilic 
surface can provide a greater range. On the hydrophilic surface, both electrostatic 
attraction and size-exclusion work in recovering proteins, but on the hydrophobic surface, 






















Figure 6.6: Mass spectra for low mass range of peptides recovered on the mesoporous 
silica chips with different hydrophilicity (top: hydrophilic surface, bottom: 
hydrophobic surface).  
6.3.2 Organic Functionalization 
Mesoporous silica possesses many silanol (Si-OH) groups on the surface that can 
act as convenient anchoring points for organic functionalization. Because of this fact, a 
post-synthesis process can be employed to anchor specific organic groups onto the 
surface of silica. [202-206] However, as we discussed above, the high temperature during 
calcinations process may cause a portion of surface silanol groups to be extensively 
dehydrated, resulting in a substrate incompatible with potentially conjugating 
organosilane groups. One-spot synthesis is also limited to use in our study due to the 
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restrictions of this method in the selection of polymer templates. To resolve the problem, 
the oxygen plasma is first used to treat the surface of mesoporous silica chip before the 
post-grafting. Not only can Oxygen plasma increase the surface hydrophilicity, but it can 
also fix the defect point (Si-H) on the surface with a high density of Si-OH groups.  
To analyze the loading efficacy of organosilianes, the XPS method has been used 
to study the composite of thin film. Figure 6.7.a shows a comparison of XPS intensity of 
C content on the APTES modified chips before and after chemical modification. The 
significant increase of C 1s peak for the chips after modification, resulting from the alkyl 
chain on APTES, validates the efficacy of post-grafting on the chip surface treated with 
oxygen plasma.  
Figure 6.7.b exhibits the comparison for N 1s peak on the 3 mesoporous silica 
chips APTES-modified under different method (black curve: N 1s on the chips after one-
spot modification, red curve: N 1s on the chips after post-grafting without any pre-
treatment, blue curve: N 1s on the chips after post-grafting method with pre-treatment by  
oxygen plasma. ) The difference for N 1s peak around the binding energy of 397 eV 
clearly implies the efficacy of oxygen plasma in grafting the functional groups on the 
pore surface.  The chip that received pre-treatment of oxygen plasma is capable of 
conjugating four times the amino content than a chip without any surface treatment. 
Although the intensity for N 1s peaks are similar, the chip carried by post-grafting with 
oxygen plasma pre-treatment consisted of a sharper and more symmetric single peak at 
binding energies around 397 eV, which strongly points to a loading of APTES with high 
condensation on the pore surface. By calculating the areas under the peaks for Si2p, O1s, 
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Cis and N1s, an atomic carbon-to-nitrogen ratio of 1:5.994 was obtained in table 6.2 to 












Figure 6.7: XPS spectra of mesoporous silica chips with APTES modification. a. 
Comparison of C content in XPS on the mesoporous silica chips before and 
after APTES modification. b. Comparison of N content in XPS on the 
mesoporous silica chips modified with one-spot synthesis (black curve), 
modified with post-grafting without pre-treatment (red curve) and modified 
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Table 6.2: The tabulated atomic concentrations of each element on the mesoporous silica 







The XPS spectra in Figure 6.7 show the conjugation of MPTES on the 
mesoporous silica chips by post-grafting. Fig.6.7.a shows the signal at 162 eV 
corresponding to the existence of thiol group on the pore surface. In Fig.6.7.b, the spectra 
showing C 1s signals on the chips before and after grafting MPTES disclose the condense 
loading of the organosilane on the pore surface. The ratio of atomic concentration of Si 







































Figure 6.7: XPS spectra of mesoporous silica chips with MPTES modification. a. S 
content in XPS on the mesoporous silica chips with MPTES modification. b. 
Comparison of C content in XPS on the mesoporous silica chips before and 
after MPTES modification.  
 
Table 6.3: The tabulated atomic concentrations of each element on the mesoporous silica 
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With the improved post-grafting pathway, we are able to conjugate many 
functional groups on the mesoporous silica chips, such as nitride and epoxy. After 
oxidizing the nitride group in hydrogen peroxide, the nitride group can be easily 
converted to carboxyl acid and become more active in attaching the biomolecules. Epoxy 
groups have   proven to be a good candidate for linking DNA, Aptmer or other 
biological species on the substrate. A double peak of C 1s respectively at 283 eV and 285 
eV is observed in Figure 6.8.a, which is corresponding to the carboxyl acid group and 
alkyl group. In Figure 6.8.b, the double peak for C 1s at 283 eV for –C-O-C- and at 285 













































Figure 6.8: XPS spectra of mesoporous silica chips with the modification of a. Carboxyl 
acid, b. Epoxy group. 
 
We also investigated the effect of chemical modification on the surface 
hydrophilicity of thin films. As displayed in Figure 6.9, contact angles were tested by 
goniometer with captive bubble contact angle measurement for all functionalized chips in 
our study. The results demonstrate that there is no significant change in the surface 
hydrophilicity with chemical modification.  
 























Figure 6.9: Images for showing surface contact angles of mesoporous silica chip and their 
functionalized derivatives with –NH2, -SH, -COOH, -Epoxy and –Cl.  
 
6.3.3 Sample Fractionation on Mesoporous Silica Chips with Chemical Modification 
In previous chapters, we extensively investigated the effect of pore size and pore 
structure on the recovery of LMW peptides and proteins from biological complexes. 
Another important factor for improving the enrichment capacity of the mesoporous silica 
chips is to resolve the complexity of biological samples in different sub-proteomes 
according to their chemical properties. We have developed mesoporous silica chips 
conjugated with chemical functional groups to provide cationic and anionic surfaces 
respectively. MS analysis of the proteomic standard solutions fractionated on the 
mesoporous silica chips prepared by L121+50%PPG and conjugated with the chemical 
functional groups (-NH2 and –SH) is presented in Figure 6.10. According to their 
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Isoelectric Point (IP), the positively charged and negatively charged LMW standards are 
captured on the anionic and the cationic chips respectively. HMW proteins remain 
excluded from the chips independently of their charge (See Figure 6.11). For example, 
Albumin has a net negative charge and remains excluded from the cationic chip. These 
results and the identical molecular cut-off offer displayed by the chips demonstrate the 
dual properties of the functionalized mesoporous silica chips: 1- the size dependant 
depletion of HMW proteins by the porous surface; 2- the specific enrichment of 











Figure 6.10: MS profiles of selectively captured peptides on the chemically modified 
chips. Positively and negatively charged MSC specifically enrich negative 




Figure 6.11: MS profiles of selectively captured or excluded  proteins on the chemically 














CONCLUSION AND SUGGESTED FUTURE WORKS 
7.1 General Conclusions 
Evidence is mounting that the low molecular-weight region of the circulatory 
proteome is a rich source of diagnostic biomarkers for the early detection of disease. 
Using surfactant-templated mesoporous silica thin films, we have developed a size-
exclusion method for rapid and specific isolation and analysis of LMW peptides from 
complex biological samples. The fractionation devices are effective and yield highly 
reproducible extracts from extremely complex biological samples. By optimizing the 
experimental parameters, we are able to process samples as small as 10 µl in a time as 
short as 30 minutes with the mesoporous silica chips.  
Besides the depletion of HMW protein, our mesoporous silica chips have allowed 
us to establish the correlation between the harvesting capacity and the physico-chemical 
properties of mesoporous silica surfaces. We fabricated a series of mesoporous silica thin 
films with a variety of nanotexutures and comprehensively explored their use in selective 
capturing and enriching LMW peptides and proteins from human serum. Different MPS 
thin film periodic nanostructures, formed using high molecular weight triblock 
copolymers such as Pluronic F127 with similar pore size distributions, can be obtained by 
tuning the polymer concentration in the precursor solution. The 3D cubic and honeycomb 
hexagonal nanostructures, which posses  more desirable nanopore interconnectivity and 
more accessible nanopore morphology, exhibit superior performance in selectively 
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enriching LMW peptides compared to  2D hexagonal structure, even though they share 
similar pore size distributions and the same molecular cut-off for serum fractionation. 
Precisely controlled variations in pore size can be achieved through the use of 
copolymers with differing hydrophobic block lengths.  The effect of pore size on the 
LMW peptide and protein recovery efficacy was investigated using MPS thin films 
prepared from four Pluronic surfactants (F127, P123, L64, L121, and L121 plus swelling 
agent) with different volume ratios of the hydrophilic and hydrophobic components to 
form pore sizes of 3nm, 4nm, 6nm, and 7nm respectively. This range of pore sizes led to 
the recovery of a different repertoire of peptides and proteins from the same serum 
sample via size and shape exclusion. The chemical functionalization of the porous silica 
surface further increases the specificity of peptides enrichment. 
The wealth of finely tunable and controlled properties on mesoporous silica 
surfaces could be used for MS-based peptide and protein profiling of complex biological 
fluids, providing a powerful tool in the selective separation and concentration of the low 
molecular weight proteome. In addition, the mesoporous silica chips may be used to 
store, protect and stabilize protein and peptide extracted from biological fluids to enable 
the collection and transport of clinical samples with simplified and cost-effective 
procedures. We further envision that our mesoporous silica chip based device may serve 
as diagnostic tool to complement histopathology, imaging, and other conventional 
clinical techniques. The mesoporous silica chips mediated identification of entire disease-
specific protein network may help in the selection of personalized therapeutic 
combinations, in the real-time assessment of therapeutic efficacy and toxicity, and in the 
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rational modulation of therapy based on changes in the protein network associated with 
the prognosis and the drug resistance of the disease. 
 
7.2 Suggested Future Works 
To obtain enhanced sensitivity and protocol standardization in the proposed study, 
the proteomic chips will be dramatically improved by 1) investigating the relationship 
between pore sizes and structures and the particular cancer-biomarkers harvested, and  2) 
integrating microfluidic circulating systems in order to achieve of increased pre-
concentration, improved automation and compactness, reduced waste generation, and 
enhanced operational simplicity.  
Proteomics research requires the development of new analytical tools and 
procedures that will allow high-throughput, sensitive analysis and data mining through 
bioinformatics. Microfluidics opens new avenues for developing application-specific 
microstructured channels and capillaries. Since no amplification process such as PCR can 
be performed in proteomics, the sensitivity and dynamic range of a microanalytical 
system are critical parameters. Microanalysis technologies, particularly microfluidics, 
offers promising key features to augment high-throughput and efficient proteomics 
research. One key feature is a decreased analysis time since going from a mm-range 
process to a µm-range allows for a gain in time of 106. In addition, the ability to control 
the aspect ratio of microfluidic systems greatly improves the surface-to-volume ratio for 
proteomic analysis where most reactions take place on the sensor surface. Integrating 
microfluidics with our proteomic nanochips will greatly improve the sensitivity and 
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efficiency of harvesting LMWP from blood serum.  Certain parameters of microfluidic 
systems need to be tested to enhance the surface contact of blood serum to the 
nanoporous silica thin film substrate. 
The individual or integral use of different MPS thin films in microfluidic system 
with carefully tailored characteristics provides a novel platform for the rapid and efficient 
analysis of the LMWP in human serum and may be implemented for the diagnosis of 
disease onset in many clinical settings.  
 
7.3 Remarks in Future Nanotechnology for Diagnostics 
        A major challenge in diagnosis for the 21st century is to be able to determine the 
exact relationship between disease biomarkers and clinical pathologies coupled with the 
ability to detect biomarkers non-invasively at an early stage of disease progression. In 
breast cancer, for instance, the goal of molecular imaging is to be able to accurately 
determine when a tumor mass has reached a population size of approximately 100-1000 
cells, in contrast to the current techniques like mammography which require more than a 
million cells for accurate clinical diagnosis. The ability of nanotechnology components to 
interact with matter on the molecular scale provides not only the capability to ascertain 
the molecular constituents of the disease, but also the way in which these constituents 
affect the totality of biological function.  The ability to incorporate an array of structural 
and chemical functionalities onto the same micro- and nanoscale architecture should also 
enable more accurate, sensitive, and precise screening of diseases which present 
themselves with more significant pathological heterogeneity. This same flexibility should 
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also enable a new generation of clinical constructs, referred to as theranostics, which 
combine both diagnostic and therapeutic elements. These theranostic constructs would 
facilitate rapid screening and therapeutic intervention while allowing for disease 
progression monitoring and therapeutic tailoring moving eventually towards a new era in 
personalized medicine.  This article has reviewed a few of the many applications of 
nanotechnology being developed for application to disease diagnosis. The nanodevices 
described herein, including nanoporous chips, nanowire biosensors, single electron 
transistors, and micro- and nanocantilevers, are able to detect extremely low 
concentrations of target proteins as well as DNA and RNA sequences of interest, many of 
them label-free, in real-time, and at-point-of-care. Researchers are also making progress 
in using nanomaterials to spot disease biomarkers both in vitro and in vivo. The 
application of gold nanoparticles in biobarcode assays can help detect protein and DNA 
signatures for a number of diseases, including cancer, at concentration limits in the 
attomolar range. In addition, with the assistance of quantum dots and magnetic 
nanoparticles, tumor imaging contrast and resolution has been significantly improved. 
Many of these nanomaterials have the potential to be incorporated with more traditional 
imaging and diagnostic techniques or can be used in conjunction with the aforementioned 
nanodevices to further enhance their diagnostic, screening, and biomarker profiling 
sensitivity and flexibility.  The development of nanodevices and nanomaterials for 
diagnostics spans  a diverse collection of disciplines, combining biology, chemistry, 
physics, materials science, and manufacturing to name a few. In order to realize its 
enormous potential, cross-discipline cooperation is essential.  This wide range of 
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expertise will be crucial in the design, fabrication, characterization, and implementation 
of future nanotechnological diagnostic platforms capable of the direct observation, 
manipulation, and analysis of the molecular signatures of disease, from a single molecule 
to an entire proteomic library. 
Personalized medicine is the concept of incorporating novel biotechnologies into 
the diagnosis and treatment for a single individual, factoring in the genetic and 
environmental variables that may affect the choice of therapy.   Nanotechnology is 
constantly refining personalized medicine through offering the ability to create devices 
capable of rapidly screening for biomarkers of diseases.   The identification of these 
biomarkers for distinct diseases will lead to more individualized therapeutic approaches.   
Through the use of nanotechnolgy, it is now obvious that the immediate study of DNA 
and proteins dramatically increases the speed and accuracy of the conventional molecular 
diagnostic methods. This approach is stretching the limits of current molecular 
diagnostics, and will eventually lead to the combination of diagnostics with therapeutics 
for the ultimate advancement of personalized medicine. Nanomaterials can be used for 
bio-labeling, which is an important element in the study of biomarkers. Proteomic 
technologies assist in the detection of biomarkers, thus facilitating the analysis of low-
abundant proteins. Molecular imaging is a valuable diagnostic modality, capable of 
combining with therapeutics and playing a key role in personalized medicine. The 
multiple functionalities that can be imparted to some nano-platforms make them 
advantageous over traditional approaches. Both nanomedicine and personal medicine 
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already exist in the clinical realm. However, the creation of new nanotechnologies will 
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